Gout

M13_GOUT

gout: A condition characterized by painful swelling of the joints, which is caused by deposition of urate crystals.

Endpoint definition

↥

Endpoint definition steps	FinnGen
Phenotype data	520210
1. Apply sex-specific rule None	520210
2. Check conditions None	520210
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — M10 Hospital discharge: ICD-9 — 2740 Hospital discharge: ICD-8 — 2740 Cause of death: ICD-10 — M10 Cause of death: ICD-9 — 2740 Cause of death: ICD-8 — 2740 KELA reimbursements: KELA codes — 212 3 out of 7 registries used, show all original rules.	12723
4. Check minimum number of events None	12723
5. Include endpoints None	12723
6. Filter based on genotype QC (FinnGen only)	12723

Control definitions (FinnGen only)

Control exclude: M13_ARTHROPATHIES

Extra metadata

Level in the ICD hierarchy: 4
First used in FinnGen datafreeze: DF2
Parent code in ICD-10: M05-M14

NAME	M13_GOUT
CONTROL_EXCLUDE	M13_ARTHROPATHIES
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	M10
HD_ICD_9	2740
HD_ICD_8	2740
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	M10
COD_ICD_9	2740
COD_ICD_8	2740
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB	212
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Gout based on the number of shared cases.

Similar with more cases:

Similar with less cases:

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	106476	34310	70743
Only index persons	80076	25035	55041
Unadjusted period prevalence (%)
Whole population	1.65	0.98	1.98
Only index persons	1.73	0.92	2.10
Median age at first event (years)
Whole population	69.14	75.51	66.10
Only index persons	68.92	75.83	65.77

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	12723	3143	9580
Unadjusted period prevalence (%)	3.44	1.07	4.22
Median age at first event (years)	67.24	70.05	66.32

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
11281: Matched controls
103900

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

3.1

323.3

2062

6927

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

3.7

323.3

1612

4484

L17

ICPC

Foot/toe symptom/complaint

3.0

323.0

3167

12059

NJ2MA

NOMESCO Finland

Measurement of mechanical axis of lower leg with X-ray

205.0

323.0

551

NH3AA

NOMESCO Finland

Foot and toes X-ray examination

9.9

323.0

1180

1211

205

Kela drug reimbursment

Chronic hypertension

3.2

323.0

5565

24468

R06.0

ICD-10 Finland

Dyspnoea

2.6

323.0

3304

14482

A49.9

ICD-10 Finland

Bacterial infection, unspecified

3.3

323.0

2067

6682

M10.9

ICD-10 Finland

Gout, unspecified

140.6

323.0

7611

1505

T90

ICPC

Diabetes non-insulin dependent

2.5

323.0

3607

16393

N02BE01

ATC

paracetamol; systemic, rectal

3.2

323.0

9563

66219

212

Kela drug reimbursment

Gout

+∞

323.0

2977

215

Kela drug reimbursment

Diabetes, non-insulin-treated

2.5

323.0

3774

17107

M17.9

ICD-10 Finland

Gonarthrosis, unspecified

5.4

323.0

1098

2028

M17.0

ICD-10 Finland

Primary gonarthrosis, bilateral

14.0

323.0

1399

1040

T92

ICPC

Gout

16.6

323.0

1006

610

M01AH05

ATC

etoricoxib; oral

2.9

323.0

6042

29386

I10

ICD-10 Finland

Essential (primary) hypertension

3.0

323.0

8337

50250

M25.5

ICD-10 Finland

Pain in joint

4.8

323.0

2826

6758

M10.0

ICD-10 Finland

Idiopathic gout

76.3

323.0

3412

587

C07AB07

ATC

bisoprolol; oral

2.5

323.0

6887

39690

A46

ICD-10 Finland

Erysipelas

5.1

323.0

3307

7813

N18.9

ICD-10 Finland

Chronic kidney disease, unspecified

6.8

323.0

2105

3373

NG1AA

NOMESCO Finland

Knee X-ray examination without contrast

11.5

323.0

1281

1146

M17.1

ICD-10 Finland

Other primary gonarthrosis

20.5

323.0

2206

1219

M13.9

ICD-10 Finland

Arthritis, unspecified

30.0

323.0

1677

601

M79.6

ICD-10 Finland

Pain in limb

2.9

323.0

3958

16448

M16.1

ICD-10 Finland

Other primary coxarthrosis

28.3

323.0

1062

380

M04AA01

ATC

allopurinol; systemic

54.7

323.0

8993

6958

C03DA01

ATC

spironolactone; oral

3.4

323.0

2200

6868

103

Kela drug reimbursment

Diabetes, insulin-treated

2.4

323.0

4408

21599

I50.9

ICD-10 Finland

Heart failure, unspecified

3.7

323.0

3370

10643

M16.0

ICD-10 Finland

Primary coxarthrosis, bilateral

21.1

323.0

615

283

288

Kela drug reimbursment

Febuxostat

143.4

323.0

362

B01AB05

ATC

enoxaparin; parenteral

2.8

323.0

3635

15057

N02AX02

ATC

tramadol; systemic, rectal

2.8

323.0

5330

25317

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

2.9

323.0

5159

23692

NFB30

NOMESCO Finland

Primary total prosthetic replacement of hip joint not using cement

71.2

323.0

530

M01AB01

ATC

indometacin; systemic, rectal

6.2

323.0

2256

4038

A02BC02

ATC

pantoprazole; systemic

2.6

323.0

7540

45499

A11CC03

ATC

alfacalcidol; systemic

9.0

323.0

785

857

I50.0

ICD-10 Finland

Congestive heart failure

3.8

323.0

1889

5227

J01DB01

ATC

cefalexin; oral

3.0

323.0

9166

61026

N18.8

ICD-10 Finland

Other chronic renal failure

7.4

323.0

954

1275

H02AB06

ATC

prednisolone; systemic

5.1

323.0

7454

28796

M19.0

ICD-10 Finland

Primary arthrosis of other joints

19.7

323.0

780

390

M05.8

ICD-10 Finland

Other seropositive rheumatoid arthritis

202.4

323.0

403

L15

ICPC

Knee symptom/complaint

3.4

323.0

1929

5863

NK4XE

NOMESCO Finland

Joint ultrasound examination not elsewhere classified

25.6

323.0

892

347

NGB20

NOMESCO Finland

Primary total prosthetic replacement of knee joint without patellar part

1284.9

323.0

1017

M10

ICD-10 Finland

Gout

17.8

323.0

2535

1660

M23.2

ICD-10 Finland

Derangement of meniscus due to old tear or injury

83.0

323.0

827

TNX10

NOMESCO Finland

Arthrocentesis, unspecified region, unspecified region

24.8

323.0

951

384

A10BA02

ATC

metformin; oral

2.4

323.0

4412

21977

E11.9

ICD-10 Finland

Type 2 diabetes mellitus, without complications

2.8

323.0

4178

18135

C08CA01

ATC

amlodipine; oral

2.4

323.0

5320

28359

GD1AA

NOMESCO Finland

Thorax X-ray examination

2.8

323.0

6182

31146

M10.3

ICD-10 Finland

Gout due to impairment of renal function

90.0

323.0

387

C03CA01

ATC

furosemide; systemic

4.1

323.0

6276

24123

B01AA03

ATC

warfarin; systemic

2.8

323.0

4012

16880

202

Kela drug reimbursment

Connective tissue diseases, rheumatoid arthritis and comparable disease

6.7

323.0

1026

1520

123

Kela drug reimbursment

Chronic disorders of vitamin D metabolism

8.7

323.0

843

960

I48

ICD-10 Finland

Atrial fibrillation and flutter

2.7

323.0

4381

19601

J01FF01

ATC

clindamycin; systemic

2.6

323.0

3346

14730

N02AJ06

ATC

codeine and paracetamol; systemic

2.8

323.0

3944

16880

NGD05

NOMESCO Finland

Partial excision of meniscus of knee, arthroscopic

6.8

321.8

871

1253

R60.0

ICD-10 Finland

Localized oedema

3.5

311.8

1701

5077

138

Kela drug reimbursment

Severe anaemia associated with chronic renal failure

8.1

309.8

744

893

M04AA03

ATC

febuxostat; oral

143.5

304.1

333

NGF25

NOMESCO Finland

Operation for osteochondritis of knee, arthroscopic

19.4

303.6

482

238

349

Kela drug reimbursment

Febuxostat

194.3

287.6

308

C09AA02

ATC

enalapril; systemic

2.3

283.9

3291

15544

M01AX05

ATC

glucosamine; oral

3.0

281.2

1900

6579

L04AX03

ATC

methotrexate; systemic (immunosuppressants)

7.0

280.7

746

1041

N19

ICD-10 Finland

Unspecified kidney failure

5.2

275.9

936

1780

E11.8

ICD-10 Finland

Type 2 diabetes mellitus, with unspecified complications

3.0

269.4

1803

6187

207

Kela drug reimbursment

Chronic arrhythmias

2.5

269.2

2518

10586

E66.00

ICD-10 Finland

Metabolic syndrome

4.9

266.9

961

1949

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

3.1

265.1

1662

5446

WX320

NOMESCO Finland

Spinalanesthesy

2.7

265.0

2201

8642

J18.9

ICD-10 Finland

Pneumonia, unspecified

2.2

264.2

3748

19329

TPH04

NOMESCO Finland

Cathetrisation of vein

2.4

262.5

2801

12603

S18

ICPC

Laceration/cut

2.1

261.4

4615

26105

72410

ICD-8 Finland

Internal derangement of joint, Other shoulder derangement

+∞

259.4

256

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

2.2

258.8

3528

17831

T84.0

ICD-10 Finland

Mechanical complication of internal joint prosthesis

24.1

249.9

370

146

M00.9

ICD-10 Finland

Pyogenic arthritis, unspecified

247.4

248.2

262

290

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation

2.5

247.1

2368

10025

M20.1

ICD-10 Finland

Hallux valgus (acquired)

12.8

247.1

463

347

7151F

ICD-9 Finland

Osteo-arthrosis and allied disorders, Osteo-arthrosis, localised, primary[OSTEOARTHROSIS PRIMARIA, POLVI]

+∞

246.2

243

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

2.1

246.1

3520

18090

FM1EE

NOMESCO Finland

Extensive structural and functional ultrasound examination of heart

2.2

244.6

3032

14595

SPAT1148

SPAT

Treatment of chronic ulcer or burn

2.7

243.7

2006

7791

NGB40

NOMESCO Finland

Primary total prosthetic replacement of knee joint with patellar part - sliding prosthesis

2180.1

241.8

241

N03AX16

ATC

pregabalin; oral

2.4

240.9

2433

10570

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

2.4

236.5

2507

11153

NF1AA

NOMESCO Finland

Hip X-ray examination

4.5

235.0

910

1982

FM1AE

NOMESCO Finland

Standard cardiac ultrasound examination

2.3

234.3

2728

12704

N17.9

ICD-10 Finland

Acute renal failure, unspecified

4.4

234.2

926

2059

R4110

NOMESCO Finland

Physiotherapy

2.2

232.5

3065

15114

E66.01

ICD-10 Finland

Obesity due to excess calories

4.8

230.8

844

1732

P01BA02

ATC

hydroxychloroquine; oral

7.8

229.3

561

688

G47.3

ICD-10 Finland

Sleep apnoea

2.3

227.6

2595

11935

Z96.6

ICD-10 Finland

Presence of orthopaedic joint implants

42.4

226.6

292

ND2AA

NOMESCO Finland

Hand and fingers X-ray examination

4.4

224.7

890

1980

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

2.3

219.7

2439

11046

J01MA12

ATC

levofloxacin; systemic

2.3

219.4

2572

11956

J01DA01

ATC

[U] cefalexin; systemic

1.9

219.0

6552

44072

A07EC01

ATC

sulfasalazine; oral, rectal

6.0

218.4

653

1061

ZXA00

NOMESCO Finland

Right side

2.1

216.6

2994

14988

C02AC05

ATC

moxonidine; oral

4.1

216.4

930

2233

TK800

NOMESCO Finland

Hemodialysis

6.4

215.3

610

924

A10BH05

ATC

linagliptin; oral

3.8

215.1

1018

2661

H02AB07

ATC

prednisone; oral

2.6

214.5

1797

7001

L28

ICPC

Limited function/disability (L)

2.5

213.5

2004

8314

E11

ICD-10 Finland

Type 2 diabetes mellitus

2.3

211.4

2327

10469

351

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation

2.4

210.9

2043

8610

M01AE02

ATC

naproxen; oral, rectal

1.9

210.8

5195

32467

E11.2

ICD-10 Finland

Type 2 diabetes mellitus, with renal complications

4.5

210.7

819

1785

R50.9

ICD-10 Finland

Fever, unspecified

2.6

209.3

1831

7299

117

Kela drug reimbursment

Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue

3.9

209.2

935

2324

I25.1

ICD-10 Finland

Atherosclerotic heart disease

2.0

207.8

3727

20690

S97

ICPC

Chronic ulcer skin

3.9

207.7

955

2433

C08CA13

ATC

lercanidipine; oral

2.5

207.3

1918

7882

A12AA04

ATC

calcium carbonate; oral

8.0

206.3

496

591

M15.9

ICD-10 Finland

Polyarthrosis, unspecified

7.9

205.9

501

608

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

2.0

205.5

3676

20368

M48.0

ICD-10 Finland

Spinal stenosis

2.8

204.8

1473

5221

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

2.5

204.8

1947

8112

2740A

ICD-9 Finland

Gouty arthropathy

+∞

203.5

201

C01AA05

ATC

digoxin; systemic

2.6

202.6

1707

6653

E11.7

ICD-10 Finland

Type 2 diabetes mellitus, with multiple complications

3.3

200.4

1129

3382

M06.0

ICD-10 Finland

Seronegative rheumatoid arthritis

248.0

199.9

211

NH3DA

NOMESCO Finland

Bilateral foot X-ray examination

39.5

198.9

260

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

3.3

195.1

1117

3384

M07.3*L40.5

ICD-10 Finland

Other psoriatic arthropathies

164.1

193.8

210

D64.9

ICD-10 Finland

Anaemia, unspecified

2.6

193.7

1671

6586

FN1AC

NOMESCO Finland

Angiography of heart and/or coronary arteries

2.0

191.4

3262

17630

C10AA01

ATC

simvastatin; oral

1.8

190.3

5885

39176

H02AB04

ATC

methylprednisolone; systemic

2.5

190.1

1669

6637

QDB10

NOMESCO Finland

Major dressing of wound of skin of lower limb

3.9

189.9

847

2095

ZXA05

NOMESCO Finland

Left side

2.1

189.6

2777

14108

I50.1

ICD-10 Finland

Left ventricular failure

3.3

187.4

1067

3215

M06.9

ICD-10 Finland

Rheumatoid arthritis, unspecified

50.9

187.2

233

C09CA01

ATC

losartan; oral

2.0

186.3

3052

16205

J01MA02

ATC

ciprofloxacin; systemic

1.8

185.5

4582

28231

127

Kela drug reimbursment

Transplant complication

8.8

184.0

417

450

B01AF01

ATC

rivaroxaban; oral

2.9

183.3

1248

4254

C10AA05

ATC

atorvastatin; oral

1.8

182.8

4937

31286

L97

ICD-10 Finland

Ulcer of lower limb, not elsewhere classified

4.5

182.1

702

1512

R03AC02

ATC

salbutamol; inhalant

1.8

179.7

4932

31361

M17

ICD-10 Finland

Gonarthrosis [arthrosis of knee]

3.7

179.6

854

2230

L04AA06

ATC

mycophenolic acid; systemic

8.5

177.4

412

463

7170A

ICD-9 Finland

Internal derangement of knee, Old bucket handle tear of medial meniscus

+∞

176.1

174

NHG80

NOMESCO Finland

Fusion of first tarsometatarsal joint

248.0

175.3

185

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

1.9

175.3

3350

18773

NH3EA

NOMESCO Finland

Feet X-ray examination with load

32.1

174.6

239

N02AA05

ATC

oxycodone; systemic

2.3

174.4

1955

8776

SPAT1263

SPAT

Sampling

1.8

174.1

4307

26380

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

2.7

174.0

1357

5022

M09AX01

ATC

hyaluronic acid; parenteral

6.6

173.9

480

699

C01DA14

ATC

isosorbide mononitrate; oral

2.0

173.2

2665

13735

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

2.3

172.7

1799

7788

N18.0

ICD-10 Finland

End-stage renal disease

8.8

172.4

392

425

NH3BA

NOMESCO Finland

Foot and toes extensive X-ray examination

9.0

171.7

384

405

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

2.4

171.5

1730

7367

C01DA08

ATC

isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal

1.9

171.1

3419

19432

E66.8

ICD-10 Finland

Other obesity

5.5

170.7

545

955

B03XA02

ATC

darbepoetin alfa; parenteral

6.2

169.9

487

746

KH1AE

NOMESCO Finland

Urinary tract ultrasound examination

3.1

169.2

1015

3167

A10BH01

ATC

sitagliptin; oral

2.5

168.4

1487

5897

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

2.2

167.5

1967

9006

K78

ICPC

Atrial fibrillation/flutter

2.7

167.4

1330

4970

I50

ICD-10 Finland

Heart failure

4.2

164.8

677

1548

NH1AA

NOMESCO Finland

Ankle X-ray examination without contrast

3.9

164.4

729

1788

WX002

NOMESCO Finland

Sedation and analgesia

2.1

164.3

2152

10334

N03AX12

ATC

gabapentin; oral

2.5

164.3

1446

5722

SPAT1262

SPAT

Handing over of treatment supplies

2.0

164.3

2462

12513

Z94.0

ICD-10 Finland

Kidney transplant status

10.4

164.2

338

306

B01AF02

ATC

apixaban; oral

2.5

163.6

1466

5854

M20.2

ICD-10 Finland

Hallux rigidus

65.1

163.1

195

C08CA02

ATC

felodipine; oral

2.4

163.1

1531

6268

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

1.9

163.0

3272

18560

L16

ICPC

Ankle symptom/complaint

3.1

162.6

994

3139

C03EA01

ATC

hydrochlorothiazide and potassium-sparing agents; oral

2.2

162.0

2012

9433

M23.9

ICD-10 Finland

Internal derangement of knee, unspecified

4.4

162.0

636

1392

XF400

NOMESCO Finland

ECG with 12 standard connections

2.1

161.7

2321

11577

Z49.1

ICD-10 Finland

Extracorporeal dialysis

7.7

161.4

397

489

UJF32

NOMESCO Finland

Coloscopy

1.9

160.9

2930

16032

C07AB02

ATC

metoprolol; systemic

1.9

160.7

2994

16516

NFB40

NOMESCO Finland

Primary total prosthetic replacement of hip joint using hybrid technique

21.5

160.3

245

107

L90

ICPC

Osteoarthrosis of knee

5.9

160.3

481

781

NE1AA

NOMESCO Finland

Pelvis X-ray examination

3.8

158.8

744

1913

WX111

NOMESCO Finland

Local infiltration anesthesia

93.6

157.7

180

N08.39*E11.2

ICD-10 Finland

Non-insulin-dependent diabetes mellitus - Diabetic nephropathy

6.8

157.7

422

588

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

2.0

157.7

2693

14366

NGA30

NOMESCO Finland

Exploration of knee joint, arthroscopic

12.0

157.0

301

236

ND2DA

NOMESCO Finland

Bilateral hand X-ray examination

30.1

156.9

218

R02

ICPC

Shortness of breath/dyspnoea

2.5

156.5

1415

5671

M54.5

ICD-10 Finland

Low back pain

1.9

155.8

2782

15077

M13.0

ICD-10 Finland

Polyarthritis, unspecified

47.0

155.4

196

J45.9

ICD-10 Finland

Asthma, unspecified

2.2

155.3

1844

8453

M20.4

ICD-10 Finland

Other hammer toe(s) (acquired)

15.3

155.2

268

165

C03AA03

ATC

hydrochlorothiazide; oral

2.5

155.1

1421

5732

M10.2

ICD-10 Finland

Drug-induced gout

74.1

155.0

182

J01CA04

ATC

amoxicillin; systemic

1.7

154.9

7670

57212

A12BA01

ATC

potassium chloride; oral

3.1

154.7

924

2867

TPH15

NOMESCO Finland

Insertion of central venous catheter through external or internal jugular vein

3.0

153.7

1011

3349

K57.3

ICD-10 Finland

Diverticular disease of large intestine without perforation or abscess

2.1

150.0

2040

9911

WX110

NOMESCO Finland

Local anesthesy

1.7

149.4

6267

44292

M05.9

ICD-10 Finland

Seropositive rheumatoid arthritis, unspecified

357.1

148.5

154

M19.1

ICD-10 Finland

Post-traumatic arthrosis of other joints

43.3

148.4

190

I70.2

ICD-10 Finland

Atherosclerosis of arteries of extremities

2.3

148.3

1623

7147

PBL10

NOMESCO Finland

Construction of arteriovenous fistula from radial artery

8.5

147.2

341

381

M01AB05

ATC

diclofenac; systemic, rectal

1.7

147.0

6168

43503

I15.1

ICD-10 Finland

Hypertension secondary to other renal disorders

8.9

146.5

329

349

M02.9

ICD-10 Finland

Reactive arthropathy, unspecified

45.5

145.8

185

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

2.6

144.6

1152

4291

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

3.1

144.3

870

2712

A10AE04

ATC

insulin glargine; parenteral

2.4

144.0

1408

5858

XPX99

NOMESCO Finland

Other diagnostic examination of periferal vessel

2.7

143.9

1070

3824

J01AA02

ATC

doxycycline; systemic

1.7

143.9

7918

60139

XW000

NOMESCO Finland

Bone marrow biopsy

3.5

140.6

724

2006

XFP20

NOMESCO Finland

Check up of cardiac pacemaker

2.6

140.6

1114

4131

ZX120

NOMESCO Finland

Intravenous

2.5

140.4

1250

4949

Z49.0

ICD-10 Finland

Preparatory care for dialysis

9.1

140.4

311

322

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

2.1

139.0

1930

9423

201

Kela drug reimbursment

Chronic cardiac insufficiency

2.7

138.3

1058

3841

R07.4

ICD-10 Finland

Chest pain, unspecified

1.8

138.2

2933

16765

AA1AD

NOMESCO Finland

CT of head and brain

1.8

137.9

2890

16448

L01BA01

ATC

methotrexate; systemic (folic acid analog.)

12.9

136.2

252

183

I25.9

ICD-10 Finland

Chronic ischaemic heart disease, unspecified

2.1

135.3

1779

8479

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

2.6

135.2

1075

3991

M16.9

ICD-10 Finland

Coxarthrosis, unspecified

5.8

134.9

410

675

C09AA05

ATC

ramipril; oral

1.8

134.9

3402

20526

M02AA07

ATC

piroxicam; topical

1.7

134.7

3567

21841

SPAT1250

SPAT

Comprehensive monitoring of chronic illness

1.8

134.5

3374

20320

M01AE03

ATC

ketoprofen; systemic, rectal

1.7

134.1

3810

23824

NHK30

NOMESCO Finland

Osteotomy or rotation osteotomy of first metatarsal or tarsal bone

136.1

132.8

146

KAS10

NOMESCO Finland

Allogenic transplantation of kidney from cadaver donor

11.2

132.7

263

221

A28

ICPC

Limited function/disability NOS

2.0

132.7

1972

9878

285

Kela drug reimbursment

Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)

3.5

132.5

666

1809

X59

ICD-10 Finland

Exposure to unspecified factor

2.1

132.0

1709

8084

E0000UV

ATC

1.7

131.6

3624

22418

AN1

Coronary angiography

2.0

130.2

1847

9070

NG2AA

NOMESCO Finland

Patella X-ray examination

21.4

130.2

199

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

1.8

130.1

3126

18531

TFP20

NOMESCO Finland

Cardiodefibrillation

2.4

129.8

1194

4799

JN3AD

NOMESCO Finland

Abdominal CT examination

2.7

129.7

1013

3717

NG1DA

NOMESCO Finland

X-ray of knees

31.8

129.3

177

D50.9

ICD-10 Finland

Iron deficiency anaemia, unspecified

2.7

128.0

964

3462

CJE20

NOMESCO Finland

Phakoemulsification with implantation of artificial lens in posterior chamber

1.7

127.2

3882

24682

G56.0

ICD-10 Finland

Carpal tunnel syndrome

2.6

126.4

1006

3729

WX408

NOMESCO Finland

General anesthesy, balanced

1.8

125.9

2802

16180

L04AA13

ATC

leflunomide; oral

47.6

125.7

158

B01AB10

ATC

tinzaparin; parenteral

2.8

125.5

867

2950

190

Kela drug reimbursment

Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide

10.7

124.2

252

222

C07AG02

ATC

carvedilol; oral

2.6

124.0

984

3641

E66.9

ICD-10 Finland

Obesity, unspecified

5.1

124.0

418

777

J01CE02

ATC

phenoxymethylpenicillin; oral

1.6

123.1

6437

47087

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.6

123.0

4487

29890

L13

ICPC

Hip symptom/complaint

2.4

122.6

1185

4878

L40.5

ICD-10 Finland

Arthropathic psoriasis

23.5

122.0

181

137

Kela drug reimbursment

Uraemia requiring dialysis

9.7

121.1

259

252

M01AH02

ATC

rofecoxib; oral

2.3

121.0

1254

5341

M75.1

ICD-10 Finland

Rotator cuff syndrome

1.9

120.5

1985

10301

PG1DE

NOMESCO Finland

Other extensive ultrasound examination of artery

3.4

120.4

648

1854

L04AD01

ATC

ciclosporin; systemic

6.8

120.1

321

446

C09BA02

ATC

enalapril and diuretics; systemic

2.3

119.6

1290

5599

TNH11

NOMESCO Finland

Injection of diagnostic or therapeutic substance in ankle joint or foot joint

151.3

119.4

130

K07

ICPC

Swollen ankles/oedema

3.4

118.7

630

1783

NB1AA

NOMESCO Finland

Shoulder X-ray examination without contrast

3.3

118.5

663

1952

C09CA06

ATC

candesartan; oral

1.9

117.8

2230

12150

L12

ICPC

Hand/finger symptom/complaint

2.3

117.7

1210

5130

Z95.0

ICD-10 Finland

Presence of electronic cardiac devices

2.8

117.5

856

3007

346

Kela drug reimbursment

Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)

3.5

117.3

594

1620

SPAT1301

SPAT

No procedures

1.7

116.9

3257

20055

M01AH01

ATC

celecoxib; oral (coxibs)

2.1

116.8

1495

7005

C02EA02

ATC

2.7

116.7

871

3104

M15.0

ICD-10 Finland

Primary generalized (osteo)arthrosis

10.7

115.8

235

207

E78.01

ICD-10 Finland

Pure hypercholesterolaemia

1.8

115.1

2413

13598

C01DA02

ATC

glyceryl trinitrate; oral, oral aerosol, sublingual, transdermal

1.7

115.1

3057

18543

1221

FHL

Arthroscopy and meniscus surgery

9.1

114.7

253

260

TNG10

NOMESCO Finland

Puncture of knee

100.1

114.0

129

J01FA06

ATC

roxithromycin; oral

1.6

114.0

3788

24460

E87.5

ICD-10 Finland

Hyperkalaemia

5.2

113.6

379

696

M13.1

ICD-10 Finland

Monoarthritis, not elsewhere classified

29.5

113.4

158

T84.5

ICD-10 Finland

Infection and inflammatory reaction due to internal joint prosthesis

24.8

113.1

165

L88

ICPC

Rheumatoid/seropositive arthritis

10.2

112.9

234

215

SPAT1254

SPAT

Administration of medicine

2.0

112.0

1690

8455

A02BC01

ATC

omeprazole; systemic

1.7

111.9

2880

17278

D07AC01

ATC

betamethasone; topical

1.7

111.9

3341

20922

FM1DE

NOMESCO Finland

Doppler ultrasound examination of heart

2.2

111.7

1239

5438

A10BB12

ATC

glimepiride; oral

2.2

111.5

1249

5507

Z71.8

ICD-10 Finland

Other specified counselling

1.9

110.8

2049

11044

TPH07

NOMESCO Finland

Cathetrisation of artery

2.1

110.4

1356

6229

SPAT1255

SPAT

Intravenous administration of medicine

2.6

110.4

865

3170

M10.4

ICD-10 Finland

Other secondary gout

90.3

110.1

126

A10AB05

ATC

insulin aspart; parenteral (insulins and analog. for injection, fast-acting)

2.4

109.7

1036

4201

73799

ICD-8 Finland

Hallux valgus and varus

+∞

109.2

108

L03.0

ICD-10 Finland

Cellulitis of finger and toe

2.9

108.7

732

2442

A08

ICPC

Swelling

3.5

108.6

546

1479

I11.9

ICD-10 Finland

Hypertensive heart disease without (congestive) heart failure

2.9

108.4

733

2454

Z01.8

ICD-10 Finland

Other specified special examinations

1.9

108.3

2046

11100

NFB50

NOMESCO Finland

Primary total prosthetic replacement of hip joint using cement

32.6

108.2

147

M01AX17

ATC

nimesulide; oral

1.8

108.0

2263

12708

A02BC05

ATC

esomeprazole; systemic

1.6

107.9

3670

23757

M19.9

ICD-10 Finland

Arthrosis, unspecified

6.4

107.7

299

438

R53

ICD-10 Finland

Malaise and fatigue

1.8

107.2

2100

11531

R5140

NOMESCO Finland

Monitoring the use of the aid

2.2

107.0

1232

5496

L04AA01

ATC

[U] ciclosporin; systemic

9.1

106.9

236

243

R04.0

ICD-10 Finland

Epistaxis

2.4

106.6

1009

4096

NA3BG

NOMESCO Finland

Lumbar spine MRI examination with high intensity magnet

2.7

106.4

817

2954

NGF35

NOMESCO Finland

Plastic operation of joint cartilage of knee

15.3

105.9

182

111

S76

ICPC

Skin infection other

3.1

105.6

631

1943

B01AX06

ATC

[U] rivaroxaban; oral

32.0

105.5

144

N05CF01

ATC

zopiclone; oral

1.6

105.2

3451

22089

206

Kela drug reimbursment

Chronic coronary artery disease and dyslipidaemia associated with chronic coronary artery disease

1.7

104.9

2930

17940

I42.0

ICD-10 Finland

Dilated cardiomyopathy

3.4

103.5

542

1515

9271

FHL

Hallux surgery

107.9

103.4

116

NF1AE

NOMESCO Finland

Hip joint ultrasound examination

10.8

103.0

207

179

B01AC04

ATC

clopidogrel; oral

1.8

102.8

2241

12723

KA2AE

NOMESCO Finland

Ultrasound examination transplanted kidney

11.6

102.7

199

160

M70.2

ICD-10 Finland

Olecranon bursitis

3.5

102.4

522

1429

NHG77

NOMESCO Finland

Arthroplasty of interphalangeal tarsal joint(s)

147.4

101.8

111

SPAT1222

SPAT

Counselling/guidance promoting independent living

1.9

101.3

1689

8743

NF1DA

NOMESCO Finland

X-ray of hips

12.7

101.2

188

138

V03AE01

ATC

polystyrene sulfonate; oral

5.7

101.1

310

516

C09CA03

ATC

valsartan; oral

2.2

101.0

1150

5095

J01MA14

ATC

moxifloxacin; systemic

2.3

101.0

1060

4521

SPAT1249

SPAT

Treatment-related counselling outside office

1.6

100.6

3674

24112

1220

FHL

Arthroscopy

6.0

100.6

296

468

J01CF05

ATC

flucloxacillin; systemic

3.6

100.5

488

1285

M77.4

ICD-10 Finland

Metatarsalgia

3.9

99.8

442

1076

L04AD02

ATC

tacrolimus; systemic (calcineurin inhibitors)

10.3

99.6

205

186

SPAT1149

SPAT

Suture or treatment of traumatic wound

2.0

99.3

1443

7086

M13.8

ICD-10 Finland

Other specified arthritis

21.0

97.2

149

R60.9

ICD-10 Finland

Oedema, unspecified

3.1

97.2

568

1721

I48.9

ICD-10 Finland

Atrial fibrillation and atrial flutter, unspecified

2.5

96.8

804

3038

J01EE01

ATC

sulfamethoxazole and trimethoprim; systemic

2.6

96.7

791

2962

SPAT1229

SPAT

Assessment of need for aid

2.4

95.6

911

3702

4019X

ICD-9 Finland

Essential hypertension, Unspecified

3.0

95.5

599

1906

NHQ40

NOMESCO Finland

Amputation of toe

4.8

95.0

338

666

7151E

ICD-9 Finland

Osteo-arthrosis and allied disorders, Osteo-arthrosis, localised, primary[OSTEOARTHROSIS PRIMARIA, LONKKANIVEL]

+∞

95.0

QDB05

NOMESCO Finland

Revision of wound of skin of lower limb

4.2

94.7

386

871

M07.3

ICD-10 Finland

Other psoriatic arthropathies

99.4

94.6

107

R5110

NOMESCO Finland

Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it

2.0

94.6

1291

6175

M01AC06

ATC

meloxicam; systemic, rectal

1.6

94.5

2857

17778

WX892

NOMESCO Finland

Monitored bed care

2.2

94.5

1021

4408

L03

ICPC

Low back symptom/complaint

1.8

93.7

1853

10149

SPAT1211

SPAT

Application of soft bandage

2.3

93.4

935

3891

NK4AT

NOMESCO Finland

Puncture of joint with ultrasound guidance not elsewher classified

41.3

93.1

120

SPAT1153

SPAT

Removal of sutures

1.6

92.8

2984

18860

SPAT1202

SPAT

Intra-articular injection

4.9

92.7

324

626

WZB00

NOMESCO Finland

Telephone receipt or other advice

1.7

92.2

2194

12735

DM1QA

NOMESCO Finland

Paranasal sinuses X-ray examination in one projection

3.4

91.8

482

1349

NFC20

NOMESCO Finland

Secondary implantation of hip prosthesis

23.0

91.3

136

M17.3

ICD-10 Finland

LabWAS

↥

(ID) Name

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

1824

6429

2.85

321.98

2.0

1.6

—

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

960

2257

4.11

321.37

4.7

2.6

2.2

1.6

mg/l

54.25

883

2029

(3009445) Proteinase 3 Ab [Units/volume] in Serum

1219

3405

3.50

318.56

1.4

1.5

11.0

15.9

u/ml

0.57

(46235355) HIV 1 and 2 tests - Meaningful Use set

2113

8083

2.66

318.32

2.1

1.6

—

(3044640) Blood type and Crossmatch panel - Blood

4792

26192

2.07

311.06

3.7

2.6

—

(40760888) Immunoglobulin light chains.free panel - Serum

945

2264

4.03

308.10

4.3

3.6

—

(3014111) Lactate [Moles/volume] in Serum or Plasma

2211

8782

2.57

307.71

8.6

7.0

1.4

mmol/l

0.09

2122

8391

(3000475) Leukocytes [#/volume] in Synovial fluid

1178

504

23.37

307.65

1.7

1.2

19100.7

15231.2

e6/l

0.59

867

343

(3031040) Bacteria [#/volume] in Urine by Automated count

8534

55910

2.19

307.65

6.3

4.4

356.2

1348.5

e6/l

4.05

118

1081

(3024561) Albumin [Mass/volume] in Serum or Plasma

7194

39415

2.53

307.65

8.4

4.9

33.7

34.6

g/l

31.40

6783

36257

(3006315) Basophils [#/volume] in Blood

7633

39236

2.93

307.65

8.1

5.1

0.0

e9/l

0.94

6663

32968

(3018418) pH of Serum or Plasma

5263

26162

2.42

307.65

8.9

4.1

7.4

3.81

1081

4998

(3002030) Lymphocytes/100 leukocytes in Blood

7274

38147

2.72

307.65

8.6

5.4

23.5

25.9

57.22

6895

35040

(3009508) Creatinine [Moles/volume] in Urine

5798

29439

2.46

307.65

4.5

3.1

7.1

7.8

mmol/l

36.17

4930

24266

(3030467) Casts [#/volume] in Urine by Automated count

4898

26066

2.16

307.65

5.0

3.2

0.6

0.5

e6/l

1.46

3979

19631

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

505

193

24.79

307.65

1.6

1.1

16.9

29.4

3.86

355

102

(3019069) Monocytes/100 leukocytes in Blood

7236

37278

2.78

307.65

8.9

5.5

9.0

0.17

6897

34440

(3000991) Gas panel - Venous blood

2391

8316

3.00

307.65

11.3

8.2

—

(3002032) Base excess in Venous blood by calculation

2616

9616

2.86

307.65

7.1

3.6

1.4

1.8

mmol/l

6.16

2161

7729

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

9832

66505

2.53

307.65

12.5

7.4

88.0

81.5

u/l

19.01

9452

62093

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

1712

660

27.16

307.65

1.5

1.1

—

(3020630) Protein [Mass/volume] in Serum or Plasma

2398

7750

3.24

307.65

3.5

2.7

65.5

66.0

g/l

1.81

2216

6971

(3004789) Transferrin [Mass/volume] in Serum or Plasma

3856

13348

3.34

307.65

4.5

2.4

2.2

2.3

g/l

9.85

3619

12231

(3013707) Erythrocyte sedimentation rate by Westergren method

9183

58073

2.59

307.65

6.2

3.3

21.4

13.4

mm/h

225.78

8635

52327

(3004588) Protein electrophoresis panel - Serum or Plasma

2071

6201

3.44

307.65

3.2

2.5

—

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

2825

7763

3.98

307.65

1.4

1.2

37.9

23.2

iu/ml

4.17

896

2047

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

2338

6058

4.08

307.65

7.4

3.7

145.0

97.9

ng/l

45.90

2066

5123

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

3545

16137

2.39

307.65

2.1

1.7

1.5

1.6

mg/l

0.87

2846

12573

(3001604) Monocytes [#/volume] in Blood

7586

39004

2.91

307.65

8.0

5.0

0.7

0.6

e9/l

7.01

6615

32708

(3007853) Bacteria identified in Skin by Aerobe culture

2456

9411

2.71

307.65

2.3

1.7

—

(3024263) Appearance of Synovial fluid

307

173

16.55

307.65

1.6

1.2

—

(3013650) Neutrophils [#/volume] in Blood by Automated count

8261

46276

2.79

307.65

12.1

8.8

4.8

4.4

e9/l

31.45

7305

39666

(3021788) Differential panel - Synovial fluid

945

297

31.25

307.65

1.5

1.1

—

(3013826) Glucose [Moles/volume] in Serum or Plasma

8464

53249

2.34

307.65

8.3

4.9

7.2

7.0

mmol/l

12.65

8140

50014

(3032080) INR in Blood by Coagulation assay

7026

39673

2.37

307.65

18.1

10.3

1.4

inr

3.60

2022

10849

(3006504) Eosinophils/100 leukocytes in Blood

7215

37060

2.79

307.65

8.5

5.3

2.7

2.8

3.03

6871

34134

(3012544) pH of Venous blood

2675

9991

2.82

307.65

7.0

3.6

7.4

0.47

(3022948) Iron [Moles/volume] in Serum or Plasma

4021

14299

3.29

307.65

4.5

2.4

11.4

12.6

umol/l

19.33

3781

13113

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

1231

3049

3.97

307.65

4.3

3.5

50.3

44.5

mg/l

0.47

998

2490

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

5536

30594

2.15

307.65

2.9

2.1

75.5

77.9

nmol/l

6.77

4997

26575

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

1615

4669

3.47

307.65

7.6

3.7

23.7

24.0

mmol/l

3.80

1467

4189

(3034860) Kappa light chains.free [Mass/volume] in Serum

1226

3054

3.94

307.65

4.3

3.5

65.8

81.9

mg/l

0.40

994

2493

(3018095) Leukocytes [#/volume] in Urine

5747

31892

2.17

307.65

6.0

3.7

97.1

128.0

e6/l

1.54

4570

23366

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

5764

29012

2.48

307.65

4.9

3.0

3187.6

1745.7

ng/l

36.32

5165

25131

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

7820

46024

2.42

307.65

8.4

6.7

12.7

12.8

umol/l

0.19

7514

43629

(3002582) Erythrocytes [#/volume] in Urine

5317

28693

2.18

307.65

5.2

3.3

73.7

134.9

e6/l

2.84

4417

22087

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

1667

4581

3.67

307.65

1.9

1.6

1.5

g/l

2.53

1478

3887

(3003458) Phosphate [Moles/volume] in Serum or Plasma

4020

12287

3.90

307.65

11.5

5.5

1.1

1.0

mmol/l

51.16

3796

11345

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

4832

22408

2.56

307.65

2.9

2.2

3.4

3.0

mg/l

15.34

4241

18731

(3017143) Hepatitis C virus Ab [Presence] in Serum

1903

6405

3.01

307.65

2.2

1.6

—

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

3155

11619

2.96

307.65

5.6

4.4

249.5

248.1

u/l

0.18

3000

10954

(3020682) Albumin/Creatinine [Ratio] in Urine

5955

30751

2.44

307.65

5.6

3.9

22.8

8.9

mg/mmol

43.07

4401

19938

(3042936) Bacteria identified in Isolate by Culture

3643

11050

3.81

307.65

2.5

1.9

—

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

7357

40594

2.55

307.65

12.5

6.1

1.2

mmol/l

0.15

6892

36388

(3037522) Nuclear Ab [Titer] in Serum

2330

7314

3.33

307.65

1.3

1.2

425.6

484.7

titre

0.89

468

1475

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

2751

6844

4.40

307.65

1.3

1.1

11.8

3.1

u/ml

8.59

901

2418

(3018010) Neutrophils/100 leukocytes in Blood

7136

37435

2.68

307.65

8.3

5.2

61.0

58.8

42.75

6788

34588

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

1065

2413

4.30

307.65

1.9

1.6

—

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

1207

2975

3.98

307.65

4.3

3.4

4.5

5.9

ratio

0.19

223

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

2723

10925

2.62

307.65

2.1

1.7

—

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

648

220

28.23

307.65

1.5

1.1

74.9

64.3

2.60

445

107

(3001122) Ferritin [Mass/volume] in Serum or Plasma

6019

31275

2.43

307.65

4.7

2.7

219.4

178.4

ug/l

9.68

5603

28290

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

7958

44771

2.66

307.65

14.2

6.8

1.2

mmol/l

2.46

6838

37375

(3037467) Urinalysis macro (dipstick) panel - Urine

8737

57556

2.22

307.65

6.5

4.0

—

(3010144) Erythrocytes [#/volume] in Synovial fluid

497

209

22.51

307.65

1.4

1.1

72430.1

176643.0

e6/l

0.90

345

126

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

6255

36911

2.07

307.65

5.8

4.0

—

(3026493) Urate [Moles/volume] in Serum or Plasma

8980

20304

11.31

307.65

5.5

2.6

3774.4

6846.3

umol/l

7.39

8077

17253

(3022217) INR in Platelet poor plasma by Coagulation assay

3065

13772

2.35

307.65

38.2

27.0

1.6

1.5

inr

2.64

331

1759

(3023368) Bacteria identified in Blood by Culture

6263

27106

3.18

307.65

6.5

4.3

—

(3023520) Reticulocytes [#/volume] in Blood

2411

8376

3.00

307.65

3.4

2.5

73.3

67.8

e9/l

8.73

1809

6394

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

1327

3755

3.48

307.65

3.6

2.9

0.3

u/ml

0.19

802

2121

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

3721

15714

2.64

307.65

2.3

1.8

—

(3000850) Epithelial cells [#/volume] in Urine

3970

19648

2.22

307.65

4.0

2.6

4.0

4.3

e6/l

0.80

3601

17155

(3013115) Eosinophils [#/volume] in Blood

7760

40466

2.92

307.65

8.5

5.3

0.2

e9/l

2.55

6846

34501

(3044941) Cell count panel - Synovial fluid

777

322

23.36

307.65

1.5

1.1

—

(42870588) Differential panel, method unspecified - Blood

5892

27306

2.80

307.65

7.8

5.2

—

(3021447) Carbon dioxide [Partial pressure] in Venous blood

2624

9643

2.86

307.65

7.1

3.5

5.9

5.8

kpa

1.80

2542

9336

(3022096) Basophils/100 leukocytes in Blood

7101

36001

2.81

307.65

8.3

5.3

0.6

1.30

6768

33211

(3012095) Magnesium [Moles/volume] in Serum or Plasma

3624

15249

2.63

307.65

4.6

3.4

0.8

mmol/l

13.58

3413

14123

(3027945) Reticulocytes/100 erythrocytes in Blood

3031

11404

2.87

307.65

3.0

2.4

1.9

1.7

22.24

2718

9950

(36304419) Bacteria [Presence] in Urine

4714

24836

2.16

307.65

4.9

3.2

—

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

2727

10935

2.62

307.65

2.2

1.8

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

1940

6679

2.94

307.65

2.2

1.5

—

(3020779) Urea [Moles/volume] in Serum or Plasma

3316

9125

4.13

307.65

12.9

6.7

14.2

10.6

mmol/l

102.78

3158

8605

(3012516) Albumin [Mass/volume] in Urine

5726

28915

2.46

307.65

4.6

3.2

505.0

340.6

mg/l

1.97

4292

18800

(3019198) Lymphocytes [#/volume] in Blood

7671

40108

2.87

307.65

8.2

5.1

1.8

1.9

e9/l

4.84

6777

34329

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

6300

37625

2.04

307.65

2.5

2.0

88.9

92.0

pmol/l

5.91

3765

20198

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

3718

12550

3.40

307.65

4.7

2.5

21.4

22.4

4.15

3256

10573

(3034891) Synovial lining cells/100 cells in Synovial fluid

232

23.65

302.93

1.5

1.1

3.3

2.3

0.33

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

4919

27387

2.04

301.18

2.5

2.1

198.1

258.8

u/l

4.76

4614

25579

(3024354) Oxygen [Partial pressure] in Venous blood

2050

7926

2.62

301.01

5.3

3.0

4.8

4.5

kpa

5.50

1968

7623

(3005719) IgG [Mass/volume] in Serum or Plasma

1565

5266

2.95

299.52

2.9

2.7

10.2

10.9

g/l

5.48

1451

4758

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

1732

6182

2.80

297.20

5.7

3.6

5.1

kpa

3.90

1617

5692

(3009343) pH of Capillary blood

1710

6112

2.79

292.38

5.7

3.6

7.4

7.95

300

751

(40758558) Short blood count panel - Blood

3944

20465

2.10

290.16

9.0

6.9

—

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

4813

26908

2.01

288.15

3.2

2.6

61.4

60.3

u/l

0.30

4499

24757

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

1663

5916

2.80

286.58

5.6

3.5

1.5

1.8

mmol/l

1.63

1173

4367

(3021960) Folate [Moles/volume] in Serum or Plasma

4066

21432

2.07

286.00

1.9

1.6

19.2

19.5

nmol/l

0.49

3622

18217

(3026782) Osmolality of Urine

3717

18963

2.11

285.12

4.3

2.8

521.7

569.6

mosm/kgh2o

41.75

3292

16103

(3019309) Folate [Moles/volume] in Red Blood Cells

3675

18673

2.12

284.87

2.1

1.8

1187.3

1141.8

nmol/l

1.93

2876

13806

(3021589) Normoblasts [#/volume] in Blood

6015

36472

1.95

283.38

16.7

9.5

0.0

e9/l

1.07

4929

29453

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

752

1638

4.38

277.44

7.2

5.9

1919.8

718.0

iu/ml

0.66

156

272

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

1304

4126

3.10

277.06

2.3

1.9

2.2

ug/l

0.02

1177

3636

(3018677) aPTT in Platelet poor plasma by Coagulation assay

3186

15458

2.17

277.02

2.7

2.0

31.0

30.1

11.15

3105

15011

(3035350) Ketones [Presence] in Urine by Test strip

6373

39673

1.93

274.63

5.0

3.4

0.0

estimate

0.80

1418

7169

(3028026) IgM [Mass/volume] in Serum or Plasma

1306

4172

3.07

272.80

2.2

2.0

1.3

1.4

g/l

0.75

1197

3732

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

1188

3589

3.22

272.67

3.2

2.3

—

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

1188

3591

3.22

272.41

3.2

2.3

7.7

7.3

g/l

7.14

917

2606

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

1186

3583

3.22

272.19

3.2

2.3

4.0

3.8

g/l

1.59

898

2500

(3009261) Glucose [Presence] in Urine by Test strip

6407

40107

1.92

269.77

5.1

3.5

0.0

estimate

0.11

1368

6949

(3021601) Nitrite [Presence] in Urine by Test strip

6336

39599

1.91

267.16

6.7

4.7

0.0

estimate

1.08

1454

7272

(3027801) Oxygen [Partial pressure] in Arterial blood

2590

11735

2.27

265.13

8.7

7.3

11.1

12.0

kpa

18.45

2478

11146

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

2590

11744

2.27

264.59

8.7

7.3

5.0

5.1

kpa

3.18

2487

11154

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

1121

3331

3.27

264.09

3.2

2.4

3.3

3.0

g/l

8.62

902

2553

(3026008) Bacteria identified in Urine by Culture

4561

25721

1.96

259.91

3.8

3.2

—

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

631

1261

4.75

258.71

3.4

2.7

2217.9

8817.2

u/ml

0.50

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

3770

19933

2.03

257.91

3.6

2.5

—

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

1052

3061

3.32

256.16

3.3

2.5

1.0

1.2

g/l

0.52

911

2560

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

1115

3367

3.21

255.56

3.2

2.3

9.8

10.5

g/l

4.63

959

2764

(3003396) Base excess in Arterial blood by calculation

2564

11744

2.24

254.57

8.8

7.3

0.6

1.1

mmol/l

4.91

2041

9130

(3033658) Prothrombin time (PT) actual/Normal

4160

22951

1.97

250.76

6.3

4.1

80.5

84.2

12.92

4050

22412

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

5836

36093

1.88

247.86

6.0

3.8

93.1

65.0

ng/l

0.79

4886

27422

(3016502) Oxygen saturation in Arterial blood

2340

10446

2.28

246.35

9.2

7.8

94.7

95.3

4.08

2264

10060

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

941

2637

3.43

242.82

1.6

201.7

241.0

titre

0.19

109

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

580

1141

4.81

242.13

1.6

1.3

—

(3021879) Hepatitis B virus core Ab [Presence] in Serum

1231

4071

2.94

240.77

1.6

1.4

—

(3037756) Immunofixation for Serum or Plasma

798

2034

3.75

237.27

1.8

1.7

—

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

938

2666

3.38

236.60

3.1

2.4

0.0

0.1

g/l

0.60

865

2394

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

4571

26426

1.90

236.46

3.9

3.3

36.2

37.8

u/l

0.64

4293

24824

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

1542

5840

2.60

232.33

8.9

7.2

24.2

24.7

mmol/l

5.07

1529

5774

(3014576) Chloride [Moles/volume] in Serum or Plasma

2689

13005

2.12

230.18

9.7

7.1

104.2

104.5

mmol/l

1.45

2631

12699

(3017181) Myelocytes/100 leukocytes in Blood

1702

6800

2.48

229.09

5.4

3.7

1.1

0.9

2.65

731

2185

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

3117

16030

2.02

225.42

3.9

2.9

1.0

1.3

e6/l

1.17

1876

9204

(3015377) Calcium [Moles/volume] in Serum or Plasma

4893

29282

1.85

224.06

4.2

3.6

2.3

mmol/l

1.07

4284

25056

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

3007

15296

2.04

223.97

4.2

3.0

1.9

1.8

e6/l

0.22

1767

8523

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

945

2796

3.25

223.15

3.0

2.3

36.2

37.3

g/l

5.70

839

2343

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

10808

83179

2.23

222.37

35.6

15.1

28.5

29.2

mg/l

1.60

10158

66075

(3026250) Tacrolimus [Mass/volume] in Blood

291

308

8.79

220.25

36.5

32.1

7.0

7.5

ug/l

2.19

266

265

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

876

2498

3.36

219.43

3.2

2.4

0.0

g/l

1.62

805

2237

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

857

2463

3.33

211.86

3.2

2.4

0.0

g/l

0.00

801

2231

(40760892) CBC W Ordered Manual Differential panel - Blood

3036

15790

1.99

210.65

7.2

4.2

—

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

806

2252

3.41

208.26

1.5

12.1

15.3

iu/ml

0.38

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

897

2680

3.21

208.10

1.4

1.3

—

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

1430

5519

2.53

205.94

1.8

1.5

—

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

1931

8569

2.24

202.83

2.3

0.2

g/l

0.82

1766

7919

(3013166) Neutrophils/100 leukocytes in Synovial fluid

162

21.05

202.48

1.5

1.1

70.0

58.1

1.51

147

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

2115

9805

2.16

198.97

3.5

2.8

9.6

10.7

umol/l

1.33

1871

8604

(3021440) Promyelocytes/100 leukocytes in Blood

1567

6410

2.40

198.63

5.4

3.7

0.2

0.1

3.37

666

2022

(3002173) Hemoglobin [Mass/volume] in Arterial blood

2063

9477

2.17

198.59

10.1

8.3

117.4

121.8

g/l

15.78

2009

9151

(3020876) Protein [Mass/time] in 24 hour Urine

441

816

5.07

197.37

2.2

1.9

0.7

1.0

g/24h

0.38

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

3403

18742

1.89

197.16

5.6

3.9

591.7

654.5

ng/l

0.17

3084

15936

(3011397) Hemoglobin [Presence] in Urine by Test strip

3379

18628

1.89

194.79

4.5

3.4

—

(3002179) Metamyelocytes/100 leukocytes in Blood

1503

6087

2.42

194.57

5.2

3.6

0.8

0.7

0.68

506

1528

(21494890) Protein electrophoresis panel - 24 hour Urine

491

1016

4.54

192.41

2.3

2.1

—

(3028626) Oxygen [Partial pressure] in Capillary blood

775

2232

3.31

190.55

3.7

2.8

8.0

7.8

kpa

3.44

730

2070

(1616796) Gas panel - Central venous blood

773

2223

3.31

190.50

5.8

3.6

—

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

571

1339

4.02

190.23

6.9

3.1

—

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

669

1755

3.61

190.02

1.4

1.2

g/l

3.72

635

1663

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

656

1704

3.65

189.05

1.4

0.3

0.2

g/l

6.56

621

1610

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

1457

5912

2.41

187.45

2.0

1.7

—

(3036670) Protein [Mass/volume] in Synovial fluid

142

22.95

183.60

1.2

1.0

38.5

39.1

g/l

0.07

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

763

2228

3.26

183.32

1.6

—

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

1912

8791

2.16

182.39

4.3

2.9

393.1

247.3

ng/l

14.36

1760

8048

(3010375) cycloSPORINE [Mass/volume] in Blood

282

366

7.16

180.27

29.8

29.6

98.5

118.9

ug/l

5.13

239

310

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

7316

51362

1.70

176.55

4.5

3.1

84.1

57.4

u/l

43.86

6770

46878

(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence

603

1550

3.67

176.32

1.3

1.2

54.3

110.0

titre

—

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

565

1395

3.82

175.08

1.9

1.4

—

(3025159) Blasts/100 leukocytes in Blood

1429

5934

2.35

173.83

5.5

3.7

0.4

0.3

0.19

544

1682

(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma

557

1375

3.82

172.62

1.9

1.4

18.9

15.1

u/ml

0.26

(3027456) Digoxin [Moles/volume] in Serum or Plasma

739

2202

3.19

171.54

3.3

3.0

0.9

0.8

nmol/l

2.81

583

1671

(3015235) Bicarbonate [Moles/volume] in Capillary blood

817

2587

3.01

170.94

4.0

3.1

23.7

24.8

mmol/l

7.59

745

2286

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

518

1231

3.96

169.27

2.0

1.4

119.6

117.2

u/ml

0.10

126

261

(40768446) Kidney Pathology biopsy report

252

309

7.56

169.22

1.9

1.6

—

(3007164) IgA [Mass/volume] in Serum or Plasma

2358

12026

1.97

168.42

1.8

1.5

3.0

2.7

g/l

2.70

1562

7004

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

718

2141

3.18

166.38

1.7

1.6

—

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

1339

5508

2.36

166.06

10.1

9.3

23.9

24.3

mmol/l

3.24

1248

5101

(3012215) Mononuclear cells/100 leukocytes in Synovial fluid

134

20.56

165.97

1.4

1.0

21.9

40.4

2.25

(3024928) Oxygen saturation in Venous blood

698

2050

3.23

165.84

4.6

3.1

—

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

1923

9177

2.07

165.09

5.3

3.5

—

(3022313) Gas panel - Capillary blood

1149

4454

2.49

162.28

6.1

3.7

—

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

692

2070

3.16

159.40

1.7

—

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

489

1167

3.93

158.78

6.2

6.0

12.2

12.0

mg/l

0.34

435

1065

(3019060) Gas panel - Arterial blood

1533

6804

2.20

158.30

5.8

4.9

—

(3014007) Fractional oxyhemoglobin in Arterial blood

1456

6349

2.23

156.96

11.0

9.4

93.0

93.6

3.05

1450

6322

(3004119) Hemoglobin [Mass/volume] in Venous blood

1436

6281

2.22

153.47

5.6

3.3

121.1

129.1

g/l

28.87

1391

6132

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

480

1164

3.87

152.38

1.5

1.2

280.9

287.1

u/ml

0.17

332

735

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

501

1255

3.75

151.87

1.4

1.2

—

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

10094

79009

1.80

148.10

9.1

6.2

42.9

41.0

mmol/mol

61.72

9420

71474

(3006217) Methemoglobin/Hemoglobin.total in Arterial blood

1435

6361

2.19

148.10

11.0

9.3

0.6

0.7

1.74

1423

6316

(3042733) HLA Ab [Presence] in Serum

214

255

7.76

147.19

5.6

4.8

—

(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood

1429

6379

2.17

144.73

11.0

9.1

1.4

0.40

1417

6329

(3021901) Oxygen saturation in Capillary blood

637

1924

3.12

144.15

3.7

2.8

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

578

1682

3.23

139.09

1.7

1.6

—

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

7867

58086

1.61

138.77

3.8

3.5

15.0

pmol/l

0.14

7063

51478

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

943

3581

2.51

138.42

2.6

2.4

648.3

724.6

ug/l

0.19

913

3399

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

9513

73866

1.69

135.15

5.0

4.2

2.1

2.4

mu/l

1.96

8666

65775

(3035947) Staphylolysin Ab [Units/volume] in Serum

223

309

6.68

134.28

1.2

1.1

4.0

4.8

iu/ml

0.21

(3048929) Epstein Barr virus Ab [Presence] in Serum

560

1642

3.21

133.03

1.4

1.2

—

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

544

1580

3.23

131.25

1.7

—

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

565

1681

3.16

130.99

1.5

1.3

—

(40767503) Oxygen content in Capillary blood by calculation

646

2080

2.93

130.60

3.6

2.5

15.8

16.3

2.54

420

1072

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

814

2960

2.61

130.50

1.9

1.8

37.2

38.7

u/l

1.10

693

2527

(3023183) Ammonium ion [Moles/volume] in Plasma

654

2124

2.90

130.17

2.9

2.5

32.6

33.9

umol/l

0.66

561

1778

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

952

3735

2.43

130.04

6.8

3.9

24.3

24.8

mmol/l

5.56

874

3410

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

5802

40252

1.58

129.86

2.7

2.3

—

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

1640

8011

1.99

129.69

3.1

2.5

50.0

51.8

u/l

0.05

1437

6877

(3008898) HLA-B27 [Presence]

391

920

3.96

129.31

1.1

1.0

—

(3037121) Protein [Mass/volume] in Urine

830

3098

2.54

126.02

4.2

3.2

0.4

0.3

g/l

4.03

480

1458

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

1098

4657

2.26

125.30

5.0

2.6

0.7

0.31

1080

4463

(3010421) pH of Blood

730

2571

2.68

124.62

6.9

4.0

7.4

4.04

652

2179

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

518

1512

3.21

123.89

1.6

32.0

5.8

iu/ml

0.98

126

361

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

1793

9180

1.91

123.04

3.0

2.4

7.6

8.7

ug/l

0.82

1544

7954

(3027315) Oxygen [Partial pressure] in Blood

665

2253

2.78

122.29

6.7

4.1

8.4

kpa

0.26

654

2186

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

1386

6531

2.05

120.63

4.1

2.9

44.4

61.7

ml/min/173m2

61.17

745

2645

(3013290) Carbon dioxide [Partial pressure] in Blood

660

2243

2.77

120.63

6.7

4.1

4.9

5.0

kpa

1.90

649

2177

(3012501) Base excess in Blood by calculation

660

2243

2.77

120.63

6.7

4.1

2.5

2.6

mmol/l

0.55

439

1527

(3029937) Albumin [Presence] in Urine by Test strip

3479

21781

1.63

116.99

5.7

3.8

0.0

estimate

0.32

1281

6687

(3000494) Fungus identified in Specimen by Culture

1769

9166

1.88

116.53

1.6

1.4

—

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

703

2521

2.63

115.64

2.7

2.3

4.0

3.6

g/l

5.56

669

2417

(3036481) Cortisol [Moles/volume] in Serum or Plasma

1351

6429

2.02

114.11

2.1

2.5

349.7

388.3

nmol/l

8.81

1251

5887

(3019550) Sodium [Moles/volume] in Serum or Plasma

10939

89518

1.81

113.47

41.5

18.4

139.6

mmol/l

0.00

10780

86834

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

236

412

5.30

112.55

1.3

1.2

—

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

3179

19639

1.63

111.92

1.9

1.7

6723444.0

24289208.4

pmol/l

2.85

2603

15818

(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

121

11.59

111.82

5.2

5.0

—

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

426

1174

3.39

111.66

1.4

1.3

—

(3024932) HLA-DR beta [Type]

183

250

6.75

111.65

1.1

—

(3006184) Hemoglobin [Mass/volume] in Capillary blood

633

2192

2.72

111.48

3.0

2.2

125.3

129.8

g/l

3.65

500

1596

(3023103) Potassium [Moles/volume] in Serum or Plasma

10944

89741

1.80

110.22

42.4

18.6

4.1

4.0

mmol/l

58.22

10770

86918

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

304

670

4.21

109.69

2.3

—

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

300

655

4.25

109.58

1.2

1.1

—

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

443

1267

3.27

109.44

1.6

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

636

2230

2.68

109.29

1.5

1.3

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

636

2230

2.68

109.29

1.5

1.3

—

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

1179

5432

2.08

108.50

12.2

10.2

—

(40768797) Stomach Pathology biopsy report

1966

10742

1.79

108.42

1.3

—

(3015171) Extractable nuclear Ab [Units/volume] in Serum

563

1860

2.84

108.35

1.2

0.7

0.8

u/ml

0.13

163

(3024471) HLA-A [Type]

182

256

6.56

108.07

1.0

—

(3052851) Hemolysis interference index of Serum or Plasma

709

2644

2.53

107.51

4.8

3.6

—

(3044889) 12 lead EKG panel

8057

61552

1.53

106.59

5.6

4.0

—

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

501

1579

2.97

104.97

1.6

1.5

—

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

486

1514

3.00

103.93

1.7

1.6

—

(3027273) Bicarbonate [Moles/volume] in Venous blood

1136

5246

2.07

103.70

6.0

3.3

24.6

25.1

mmol/l

4.70

1102

5094

(3002385) Erythrocyte distribution width [Ratio]

8714

67949

1.54

102.52

39.8

18.8

14.6

13.8

267.14

8606

66108

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

2775

16917

1.63

101.49

3.4

2.5

mmol/l

9.91

2388

14667

(3029634) Reagin Ab [Titer] in Serum by VDRL

328

819

3.72

99.70

2.5

2.6

4.8

5.3

titre

—

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

846

3541

2.26

98.93

2.7

2.8

—

(40761511) CBC panel - Blood by Automated count

10579

86634

1.67

97.29

30.9

14.6

—

(3008152) Bicarbonate [Moles/volume] in Arterial blood

1288

6364

1.94

96.88

9.6

7.3

24.0

24.5

mmol/l

4.08

1222

5953

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

540

1858

2.72

96.13

2.0

1.9

14.9

11.4

mg/l

3.34

487

1717

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

391

1122

3.25

96.02

1.3

1.2

—

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

157

214

6.76

96.00

1.1

—

(40761535) Cells panel - Urine sediment

1423

7289

1.88

95.90

5.0

3.3

—

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

4485

30840

1.50

94.97

5.6

3.7

—

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

420

1267

3.09

94.90

1.5

—

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

442

1378

2.99

94.34

1.6

1.4

—

(3012565) Volume of 24 hour Urine

214

402

4.92

93.98

2.7

2.3

1802.1

1986.0

1.36

187

343

(3026470) Cobalt [Mass/volume] in Blood

101

185.56

93.87

2.0

4.6

1.2

ug/l

—

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

158

227

6.41

91.98

1.1

1.0

—

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

1568

8394

1.80

91.39

2.0

1.8

1.6

12.93

1297

7201

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

404

1235

3.05

89.21

1.5

1.4

—

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

628

2416

2.44

88.84

2.4

2.2

89.4

86.2

2.62

600

2272

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

363

1045

3.23

88.66

1.6

1.7

—

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

10857

90038

1.68

88.22

18.1

10.0

27.4

26.8

u/l

1.81

10566

85883

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

9845

79813

1.55

87.47

31.9

14.9

63.1

75.6

ml/min/173m2

307.65

8698

65547

(3004809) Band form neutrophils/100 leukocytes in Blood

463

1545

2.80

87.31

4.2

3.7

1.3

1.5

1.00

358

1178

(3047189) Immunofixation for 24 hour Urine

222

458

4.48

87.15

1.8

—

(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood

1022

4836

2.01

86.67

6.5

3.9

49.3

47.4

1.54

1008

4775

(3020564) Creatinine [Moles/volume] in Serum or Plasma

10869

90278

1.67

86.25

40.0

18.3

114.8

85.0

umol/l

297.69

10864

90228

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

476

1626

2.73

85.85

1.3

1.4

49.1

36.6

u/l

0.91

433

1395

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

392

1204

3.03

85.84

1.3

—

(3028271) Lactate [Moles/volume] in Capillary blood

458

1541

2.77

85.02

2.4

1.8

1.7

1.8

mmol/l

1.22

452

1495

(3007566) Smooth muscle Ab [Titer] in Serum

532

1932

2.58

84.96

1.2

95.1

156.8

titre

0.89

167

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

1424

7598

1.80

83.44

8.4

3.8

1.2

mmol/l

4.53

1303

6538

(3044927) Protein electrophoresis panel - Urine

326

914

3.31

83.09

1.4

1.2

—

(3023420) DNA double strand Ab [Units/volume] in Serum

209

434

4.45

81.39

1.3

23.4

22.9

iu/ml

—

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

183

345

4.89

80.07

2.9

2.7

—

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

569

2196

2.43

79.83

2.5

2.4

226.7

206.3

5.21

551

2092

(3018461) Alpha 1 globulin [Mass/time] in 24 hour Urine by Electrophoresis

102

105

8.92

78.81

5.4

4.9

52.4

48.9

ug/min

0.19

(3020891) Body temperature

864

3979

2.05

78.75

7.5

4.9

—

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

294

822

3.31

75.27

1.2

59.4

70.1

u/l

0.75

200

539

(3025941) Bacteria identified in Stool by Culture

817

3748

2.05

75.17

1.4

1.3

—

(44806118)

319

943

3.14

74.56

1.8

1.6

—

(44790049)

319

944

3.13

74.42

1.8

1.5

—

(44790048)

319

944

3.13

74.42

1.8

1.5

—

(44790047)

319

944

3.13

74.42

1.8

1.5

—

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

376

1227

2.85

73.86

1.2

3.9

7.4

u/ml

1.40

207

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

335

1026

3.03

73.71

1.2

2.3

6.3

u/ml

0.90

(3014148) Varicella zoster virus Ab [Titer] in Serum

244

614

3.67

73.35

1.1

—

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

372

1218

2.84

72.63

1.2

17.8

5.0

u/ml

0.69

131

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

389

1311

2.76

71.94

1.2

45.8

39.6

u/ml

0.10

(3017704) Immunofixation for Urine

219

518

3.90

71.89

1.8

1.6

—

(3018405) Lactate [Moles/volume] in Arterial blood

777

3565

2.05

71.38

5.4

4.2

1.6

1.4

mmol/l

1.66

761

3496

(3009542) Hematocrit [Volume Fraction] of Blood

9158

74200

1.45

70.97

34.8

16.7

38.0

39.4

25.86

5758

48574

(3036489) Thrombin time

699

3101

2.12

70.21

2.3

2.0

22.4

22.0

0.79

648

2797

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

9663

79161

1.47

70.01

5.0

4.1

1.6

1.3

mmol/l

211.43

8774

70784

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

822

3892

1.99

69.14

2.5

1.9

—

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

578

2391

2.26

69.09

1.5

—

(3019832) Treponema pallidum Ab [Presence] in Serum

578

2406

2.25

68.06

1.9

1.6

—

(3052318) Alpha-1-Microglobulin [Mass/volume] in Urine

119

7.63

67.65

2.8

2.4

132.7

55.3

mg/l

—

(3013201) Beta-2-Microglobulin [Mass/volume] in Serum or Plasma

266

749

3.28

67.35

2.3

1.8

5.4

4.1

mg/l

3.08

255

706

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

9992

82622

1.48

66.75

6.2

4.8

6.5

6.1

mmol/l

88.83

9119

73822

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

250

683

3.38

66.40

1.1

—

(3041096) Erythrocytes [Presence] in Urine by Automated

3131

21208

1.46

66.08

5.1

3.3

—

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

10201

84779

1.49

65.58

6.3

5.1

2.3

2.6

mmol/l

197.92

9375

76697

(3024891) Influenza virus A+B Ag [Presence] in Specimen

494

1958

2.35

65.20

1.3

1.2

—

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

760

3577

2.00

64.93

2.2

1.8

—

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

616

2685

2.15

64.67

2.7

2.4

198.5

113.5

ug/min

2.88

370

1611

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

9959

82544

1.46

63.21

5.6

4.6

4.1

4.4

mmol/l

169.01

9202

75005

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

264

771

3.17

62.99

1.6

1.5

—

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

9877

81772

1.45

62.71

5.5

4.5

1.2

1.4

mmol/l

288.89

9048

73736

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

278

847

3.04

61.74

1.7

—

(3013512) EKG study

3811

27036

1.41

61.44

5.8

4.1

—

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

288

899

2.96

61.31

1.7

—

(3045142) Bone marrow Pathology biopsy report

334

1131

2.74

61.21

1.3

—

(3007461) Platelets [#/volume] in Blood

11004

93236

1.56

61.16

48.4

22.1

230.3

237.2

e9/l

19.62

10781

89830

(3024731) MCV [Entitic volume]

11006

93276

1.56

60.87

48.2

22.0

92.8

91.4

132.45

10885

91236

(3026361) Erythrocytes [#/volume] in Blood

11006

93280

1.56

60.81

48.4

22.1

4.3

4.5

e12/l

263.47

10741

89459

(3035941) MCH [Entitic mass]

11004

93263

1.56

60.75

48.2

22.0

30.6

30.5

8.51

10884

91220

(3010813) Leukocytes [#/volume] in Blood

11006

93296

1.56

60.57

48.5

22.1

7.6

6.9

e9/l

81.96

10749

89487

(3000963) Hemoglobin [Mass/volume] in Blood

11006

93301

1.56

60.49

48.7

22.2

129.1

136.0

g/l

289.22

10877

91249

(40768804) Tissue Pathology biopsy report

4448

32480

1.38

60.01

2.4

2.2

—

(3000093) Morphology [Interpretation] in Blood Narrative

281

885

2.94

58.89

1.1

—

(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood

188

464

3.73

58.18

3.6

2.6

31.3

36.2

1.70

153

(3003434) Protein [Mass/volume] in Pleural fluid

442

1759

2.34

57.77

1.6

1.4

28.3

32.7

g/l

10.34

397

1561

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

256

774

3.06

57.63

1.8

1.7

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

256

774

3.06

57.63

1.8

1.7

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

256

774

3.06

57.63

1.8

1.7

—

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

6367

49390

1.35

57.52

4.9

5.2

3.6

3.9

ug/l

0.38

5607

44064

(3011412) CD3 cells [#/volume] in Blood

235

676

3.21

57.51

2.5

2.3

1.0

1.1

e9/l

0.19

151

422

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

284

914

2.87

57.25

3.5

2.9

—

(3019225) pH of Specimen

1481

8787

1.61

57.14

8.9

4.3

—

(3025315) Body weight

9.90

55.93

4.8

5.6

—

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

2090

13448

1.50

55.90

1.2

2.1

u/ml

0.06

483

3351

(3022145) Colonoscopy Study observation

1512

9069

1.59

55.64

1.4

1.3

—

(3036071) Salmonella sp Ab [Titer] in Serum

8.02

54.87

1.2

1.1

—

(40761536) Microorganisms panel - Urine sediment

1220

7036

1.64

52.57

6.4

3.8

—

(3036603) Volume of Urine

200

553

3.33

52.19

1.7

1.8

1886.7

1892.6

0.01

162

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

411

1673

2.28

50.97

1.6

1.4

—

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

821

4292

1.79

50.52

6.5

5.2

1.7

0.43

774

4052

(3017354) Segmented neutrophils/100 leukocytes in Blood

274

933

2.71

49.72

3.9

3.7

61.4

59.1

0.72

167

582

(3019150) Specific gravity of Urine by Refractometry

2561

17484

1.42

49.49

5.5

3.8

1.0

kg/l

4.66

386

2679

(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood

186

510

3.36

49.21

2.1

1.9

13.6

15.9

1.02

196

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

181

488

3.41

49.16

2.1

1.9

—

(1175426) CD3 cells/100 lymphocytes in Blood

188

521

3.32

48.91

2.2

1.9

70.8

69.7

0.29

176

494

(3043409) Potassium [Moles/volume] in Arterial blood

629

3061

1.92

48.54

6.0

4.4

4.0

3.9

mmol/l

1.35

594

2852

(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma

175

468

3.44

48.14

1.3

108.0

103.8

u/l

0.18

153

396

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

459

2007

2.12

47.70

1.3

1.2

—

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

219

680

2.97

47.13

1.8

—

(3004616) Nuclear Ab [Presence] in Serum

208

628

3.05

47.00

1.3

1.2

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

459

2019

2.11

46.97

1.3

1.2

—

(21494434) Karyotype in Bone marrow

266

919

2.67

46.94

1.2

—

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

260

889

2.70

46.82

1.2

44.0

48.2

u/ml

0.12

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

170

455

3.44

46.72

1.3

34.1

30.9

u/l

0.27

150

380

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

178

491

3.34

46.67

4.6

3.5

—

(42529406) Shigella sp [Presence] in Stool by Culture

459

2027

2.10

46.49

1.3

1.2

—

(3016650) Hepatitis A virus Ab [Presence] in Serum

308

1150

2.48

46.37

1.1

—

(3016750) Collection duration of Urine

209

639

3.01

46.21

2.5

2.1

504.0

497.6

min

0.36

152

453

(3007930) Methemoglobin/Hemoglobin.total in Blood

796

4233

1.76

46.13

6.6

5.2

0.8

0.9

3.48

751

3989

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

3052

21686

1.37

45.99

1.7

1.6

1.7

1.3

mmol/l

43.25

2564

17756

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

187

540

3.19

45.55

2.9

2.5

517.0

538.1

e6/l

0.15

204

(3037556) Urate [Mass/volume] in Serum or Plasma

113

230

4.51

45.25

1.8

1.5

—

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

311

1180

2.44

45.24

1.1

—

(3045414) Leukocytes [Presence] in Urine

645

3239

1.86

45.15

2.3

1.8

—

(3023199) Leukocytes [#/volume] in Pleural fluid

379

1574

2.23

44.81

1.7

1.4

1665.2

3456.5

e6/l

1.49

270

1147

(3001729) Color of Synovial fluid

15.62

44.80

1.6

1.3

—

(3047181) Lactate [Moles/volume] in Blood

602

2972

1.89

44.43

7.9

6.5

1.5

1.3

mmol/l

1.57

541

2635

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

209

659

2.92

43.79

1.3

1.2

—

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

171

482

3.26

43.34

1.6

9.3

5.6

u/l

0.93

223

(3030981) Hyaline casts [#/volume] in Urine by Automated count

949

5393

1.65

43.01

4.4

2.8

0.3

e6/l

0.05

938

5299

(3039162) Centromere protein B Ab [Units/volume] in Serum

190

574

3.05

42.92

1.2

1.3

84.0

37.8

u/ml

—

(3022493) Free Hemoglobin [Mass/volume] in Plasma

152

400

3.49

42.90

6.6

6.1

1056.2

1130.0

mg/l

0.02

119

272

(3012441) Differential panel - Pleural fluid

337

1358

2.30

42.81

1.6

1.5

—

(21494815) CD4 cells/100 lymphocytes in Specimen

206

654

2.90

42.65

2.2

2.1

39.6

36.2

0.37

(3005322) IgE [Units/volume] in Serum or Plasma

671

3474

1.80

42.52

1.3

434.8

303.1

u/ml

1.25

605

3212

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

198

625

2.92

41.43

1.5

—

(3048689) Calprotectin [Mass/mass] in Stool

1169

7059

1.56

41.11

2.1

2.2

205.9

169.4

ug/g

1.48

948

5499

(43055442) Apixaban [Mass/volume] in Serum or Plasma

141

5.39

40.93

1.8

1.6

122.9

103.1

ug/l

0.78

113

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

765

4171

1.71

40.47

2.3

2.4

27.8

28.7

au/ml

0.04

166

(3000570) Elastase.pancreatic [Mass/mass] in Stool

495

2362

1.95

40.45

1.5

1.4

253.2

248.7

ug/g

0.19

326

1438

(3042631) Mycobacterium sp identified in Specimen

347

1450

2.21

40.43

2.5

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

270

1012

2.46

40.35

4.2

—

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

196

626

2.88

40.16

1.2

81.0

153.9

titre

1.58

(3049717) Cytology report of Urine Cyto stain

841

4723

1.67

39.83

2.8

2.9

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

165

481

3.15

39.62

1.4

1.5

—

(3046294) Neutrophil cytoplasmic Ab.classic [Titer] in Serum

195

626

2.87

39.59

1.2

68.0

113.0

titre

—

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

156

440

3.26

39.54

2.9

2.5

608.0

514.6

e6/l

0.67

131

378

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

165

482

3.15

39.48

1.4

1.5

—

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

698

3738

1.74

39.36

1.2

1.3

52.9

54.9

au/ml

0.07

163

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

176

536

3.02

39.25

1.5

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

176

537

3.01

39.12

1.5

—

(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction

295

1169

2.33

38.98

1.4

1.3

272.2

570.3

u/l

3.03

279

1106

(3028308) Erythrocytes [#/volume] in Pleural fluid

342

1443

2.19

38.92

1.6

1.4

55039.2

62586.1

e6/l

0.20

209

881

(3004716) Salmonella sp identified in Stool by Organism specific culture

529

2623

1.87

38.49

1.3

—

(40768806) Pleura Pathology biopsy report

330

1382

2.21

38.26

1.6

1.5

—

(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture

10.04

37.96

4.2

3.1

—

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

149

421

3.25

37.68

2.9

2.5

0.2

e9/l

0.09

130

376

(3035611) Eosinophils/100 leukocytes in Synovial fluid

14.54

36.85

1.8

1.3

0.4

2.1

1.16

(3036782) Glucose [Moles/volume] in Pleural fluid

286

1150

2.30

36.56

1.4

1.3

6.4

mmol/l

0.03

272

1052

(3017732) Neutrophils [#/volume] in Blood

830

4754

1.63

36.31

3.7

2.9

4.7

4.2

e9/l

3.86

566

3498

(3024980) IgG subclass 4 [Mass/volume] in Serum

267

1051

2.34

35.85

1.4

1.7

0.7

1.0

g/l

3.18

195

790

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

121

310

3.58

35.62

1.1

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

121

310

3.58

35.62

1.1

—

(4035726)

1289

8201

1.48

35.20

1.5

1.4

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

120

309

3.56

35.07

1.1

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

120

309

3.56

35.07

1.1

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

120

310

3.55

34.90

1.1

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

120

310

3.55

34.90

1.1

—

(3033799) Differential panel - Peritoneal fluid

123

324

3.48

34.74

2.4

1.9

—

(3045788) Cell count panel - Pleural fluid

293

1219

2.22

34.55

1.6

1.5

—

(3010503) CD19 cells [#/volume] in Blood

154

469

3.02

34.39

2.5

0.2

0.4

e9/l

0.83

149

451

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

184

620

2.73

34.19

1.5

—

(3045716) Anion gap in Serum or Plasma

144

425

3.11

33.94

2.2

2.1

9.4

9.1

mmol/l

0.35

122

307

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

180

608

2.72

33.30

1.5

—

(3004775) Volume in Urine collected for unspecified duration

243

949

2.36

33.25

2.4

2.3

778.3

674.6

2.58

165

610

(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid

242

944

2.36

33.20

1.3

13.7

14.1

u/l

0.05

217

876

(3002256) Pathology report gross observation

1675

11306

1.40

33.11

1.4

1.3

—

(3023419) Bacteria identified in Sputum by Culture

290

1223

2.19

33.09

2.0

2.2

—

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

162

520

2.86

32.97

2.0

2.3

127.8

99.9

ug/min

0.29

127

(3037441) Creatinine [Moles/volume] in Peritoneal dialysis fluid

13.11

32.84

5.8

6.0

380.4

434.4

umol/l

0.61

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

673

3749

1.67

32.78

3.0

3.5

4.2

4.4

pmol/l

8.42

591

3306

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

149

458

2.99

32.77

1.8

1.9

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

149

458

2.99

32.77

1.8

1.9

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

149

458

2.99

32.77

1.8

1.9

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

149

458

2.99

32.77

1.8

1.9

—

(3029856) Leukocytes [#/volume] in Peritoneal dialysis fluid

9.90

32.60

14.8

9.5

126.5

237.2

e6/l

0.90

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

811

4740

1.60

32.60

2.6

2.4

—

(3002067) Lambda light chains [Mass/time] in 24 hour Urine

158

4.52

31.53

3.1

3.4

—

(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma

133

403

3.03

30.02

1.1

42.3

29.4

u/l

0.70

107

283

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

141

445

2.91

29.64

1.5

1.6

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

141

445

2.91

29.64

1.5

1.6

—

(40765096) Chromosome analysis panel by Banding

107

286

3.43

29.62

1.2

1.1

—

(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum

138

431

2.94

29.56

1.2

23.4

37.7

u/ml

—

(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma

132

404

3.00

29.30

1.1

104.4

95.8

u/l

0.28

113

297

(3024139) IgG subclass 3 [Mass/volume] in Serum

174

624

2.56

28.65

1.4

0.4

g/l

0.24

113

428

(3028192) IgG subclass 2 [Mass/volume] in Serum

174

625

2.56

28.56

1.4

2.6

3.1

g/l

2.28

112

432

(3027135) IgG subclass 1 [Mass/volume] in Serum

174

625

2.56

28.56

1.4

7.1

7.3

g/l

0.22

113

428

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

115

331

3.19

28.33

2.6

2.0

12797.5

6464.7

e6/l

0.48

182

(3027874) Urate [Moles/volume] in Urine

11.91

28.22

1.1

1.0

1.3

1.8

mmol/l

0.75

(3023487) Leukocytes [#/volume] in Peritoneal fluid

125

380

3.02

28.09

2.8

2.1

671.2

3504.2

e6/l

0.78

262

(40766048) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum by Immunoassay

131

410

2.93

27.98

1.2

1.1

1.8

1.9

u/ml

—

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

247

1046

2.17

27.96

1.1

1.6

g/l

1.53

226

935

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

242

1017

2.19

27.92

1.6

1.5

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

146

488

2.75

27.64

1.3

1.2

—

(3003694) ABO and Rh group [Type] in Blood

2932

22015

1.28

27.34

1.4

1.3

—

(3045424) Erythrocytes [Presence] in Urine

271

1201

2.08

27.29

1.6

1.4

—

(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma

213

859

2.28

27.15

1.5

1.4

15.0

12.8

u/l

3.65

202

826

(3025468) Yersinia sp identified in Specimen by Organism specific culture

233

977

2.20

27.04

1.7

1.5

—

(40771922) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood

6.53

26.98

1.2

1.5

0.6

1.1

ml/s/173m2

1.31

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

259

3.43

26.94

1.2

—

(4062490)

171

627

2.51

26.92

1.4

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

233

979

2.19

26.91

1.7

1.5

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

233

979

2.19

26.91

1.7

1.5

—

(3035880) pH of Pleural fluid

182

688

2.43

26.85

1.3

—

(3002331) Protein [Mass/volume] in Peritoneal fluid

238

3.54

26.80

1.7

1.3

28.7

25.6

g/l

1.06

185

(3040151) Glucose [Moles/volume] in Capillary blood

274

1229

2.05

26.73

9.5

13.9

7.5

mmol/l

0.02

236

1015

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

234

988

2.18

26.70

1.6

1.5

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

118

358

3.02

26.63

1.9

2.2

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

118

358

3.02

26.63

1.9

2.2

—

(36660697) Celiac disease serology panel - Serum

785

4767

1.53

26.59

1.2

—

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

179

676

2.43

26.47

1.6

27.2

27.1

u/ml

0.01

161

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

118

360

3.01

26.38

1.9

2.2

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

234

993

2.17

26.37

1.7

1.5

—

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

115

349

3.02

25.96

1.2

—

(3026692) Albumin [Mass/volume] in Peritoneal fluid

270

3.33

25.94

1.8

1.5

15.7

12.8

g/l

2.65

205

(21494814) CD8 cells/100 lymphocytes in Specimen

104

302

3.16

25.30

1.8

2.0

—

(3005532) Lymphocytes/100 leukocytes in Pleural fluid

135

455

2.72

25.20

1.4

63.3

64.6

0.13

382

(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection

279

3.22

24.64

1.8

2.0

30454.8

30948.2

u/ml

0.00

(44816559) Phosphatidylethanol [Mass/volume] in Blood

272

1255

2.00

24.58

1.3

1.4

—

(3006245) CD3-CD19+ cells/100 cells in Blood

217

3.54

24.56

2.5

1.8

11.3

12.8

0.27

192

(3007449) CD3+CD8+ (T8 suppressor) cells/100 cells in Blood

219

3.51

24.23

2.5

1.8

35.2

28.7

2.21

201

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

222

955

2.14

24.21

1.2

4.3

3.9

u/ml

0.09

326

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

291

1387

1.93

23.96

1.1

1.2

—

(4010399)

906

5793

1.46

23.80

1.4

1.5

—

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

222

3.46

23.74

1.1

1712.9

1590.7

miu/ml

0.44

222

(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma

276

1296

1.96

23.74

2.5

2.7

996.7

1272.1

u/ml

0.11

268

1268

(3000034) Microalbumin [Mass/volume] in Urine

210

892

2.16

23.66

4.0

2.9

112.2

43.1

mg/l

2.51

169

659

(3039000) Anion gap in Blood

410

2183

1.74

23.60

9.3

7.4

12.3

11.2

mmol/l

7.60

374

1975

(3018572) Chloride [Moles/volume] in Blood

410

2183

1.74

23.60

9.4

7.4

104.7

105.0

mmol/l

0.72

374

1975

(3022764) Mononuclear cells/100 leukocytes in Peritoneal fluid

12.89

23.60

8.5

9.8

44.2

51.7

0.46

(3012898) Urea [Moles/volume] in Urine

5.53

23.47

1.4

133.9

157.9

mmol/l

0.63

(42870325) Hepcidin 25 amino acid peptide [Moles/volume] in Serum or Plasma

4.90

23.24

1.1

1.2

10.9

100008.4

nmol/l

0.49

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

229

1016

2.07

23.07

3.4

3.6

—

(3033670) Parathyrin related protein [Moles/volume] in Serum or Plasma

127

4.32

23.06

1.1

38.1

5.2

pmol/l

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

323

5143

0.56

23.02

1.9

—

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

214

929

2.12

22.83

1.2

4.2

3.8

u/ml

0.24

101

435

(3000492) Spirometry study

1036

6843

1.41

22.78

1.7

1.5

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

1147

7712

1.39

22.73

1.3

—

(3040562) Leukocytes [#/volume] in Peritoneal dialysis fluid by Manual count

11.53

22.10

9.6

10.6

—

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

1541

10896

1.33

22.05

3.3

4.4

23.8

31.3

ug/l

0.40

1275

9192

(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal

197

842

2.15

21.89

1.2

1.9

1.3

nmol/l

6.92

184

768

(40768443) Skin Pathology biopsy report

598

3570

1.55

21.86

1.3

1.2

—

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

153

588

2.39

21.86

1.1

1.2

—

titre

—

(3004451) EKG impression Narrative

133

480

2.54

21.74

1.4

1.3

—

(3002619) Bacteria identified in Specimen by Culture

130

4.15

21.56

1.4

1.3

—

(3000060) B lymphocytes [#/volume] in Blood

132

4.09

21.14

2.4

1.8

5403.2

2288.9

e6/l

0.26

(3000012) Reticulocyte production index

146

558

2.40

21.14

1.8

1.5

—

(3022621) pH of Urine by Test strip

843

5437

1.44

21.12

3.8

2.9

—

(21494755) Public health laboratory ask at order entry panel

310

4861

0.57

20.88

1.4

—

(3002621) Streptococcal DNAse B [Units/volume] in Serum

6.21

20.62

1.0

1.1

—

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

136

511

2.44

20.45

3.3

3.5

—

(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection

6.09

20.25

6.9

5.4

—

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

177

3246

0.49

20.02

1.5

—

(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination

186

806

2.12

19.99

2.2

2.1

2651.4

3269.0

titre

—

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

4880

39663

1.20

19.99

4.2

4.4

23.6

22.1

7.83

2367

20620

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

152

607

2.30

19.95

1.3

1.1

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

118

420

2.58

19.88

2.5

1.9

—

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

268

3.01

19.85

1.7

1.9

—

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

219

1012

1.99

19.80

2.8

2.1

30.7

30.6

mg/l

0.00

265

(40768795) Lymph node Pathology biopsy report

189

829

2.09

19.69

1.3

1.2

—

(3008536) Aspergillus sp Ab [Presence] in Serum

178

3.50

19.57

2.1

—

(3017569) Oxygen content in Arterial blood

127

472

2.47

19.57

2.4

2.2

—

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

285

2.92

19.55

1.8

1.5

76.8

115.4

umol/l

1.55

145

(3044007) Cell count panel - Peritoneal fluid

306

2.84

19.41

2.8

2.0

—

(3014051) Protein [Presence] in Urine by Test strip

323

1702

1.75

19.35

3.0

2.1

—

(21491868) Cryoglobulin [Mass/volume] in Serum

253

3.04

19.32

1.2

0.4

0.5

g/l

—

(3001893) Eosinophils/100 leukocytes in Pleural fluid

111

389

2.61

19.31

1.4

2.4

2.9

0.34

334

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

327

2.77

19.31

1.4

1.3

—

(40757494) Bilirubin.total [Moles/volume] in Blood

132

503

2.41

19.28

2.5

2.2

29.7

36.7

umol/l

0.19

(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma

134

3.89

19.14

2.9

1.6

195.5

150.8

ng/l

0.88

134

(3003181) Sodium [Moles/volume] in Urine

322

1707

1.74

18.90

1.4

1.3

54.0

61.8

mmol/l

3.61

250

1344

(3013727) Leukocytes other/100 leukocytes in Blood

336

2.70

18.36

4.5

3.7

55.3

54.7

0.10

321

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

177

3.41

18.34

1.4

1.2

—

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

198

909

2.00

18.27

1.2

1.1

113.8

112.3

0.20

187

807

(3003327) Ova and parasites identified in Stool by Light microscopy

355

1954

1.67

18.17

1.6

1.7

—

(3051651) Icteric interference index of Serum or Plasma

150

623

2.21

17.99

5.9

4.1

—

(3048879) Bone marrow aspiration report

300

2.78

17.85

1.7

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

190

870

2.01

17.68

1.1

—

(3003338) MCHC [Mass/volume]

8114

69314

1.18

17.62

43.9

19.9

329.5

332.8

g/l

153.93

8039

68515

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

5.85

17.32

1.0

1.1

—

(3004437) Lymphocytes/100 leukocytes in Peritoneal fluid

4.47

17.30

2.6

2.2

64.6

58.3

0.43

(4268621)

147

617

2.19

17.20

2.3

—

(3037692) Legionella sp identified in Specimen by Organism specific culture

322

2.67

17.16

1.5

1.6

—

(3051611) Lipemic interference index of Serum or Plasma

216

1048

1.89

16.99

5.3

3.7

—

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

423

2479

1.57

16.83

1.6

1.7

—

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

100

358

2.56

16.73

1.1

1.2

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

215

1048

1.88

16.69

1.1

—

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

114

438

2.38

16.42

2.3

2.5

—

(3026389) Candida sp identified in Specimen by Organism specific culture

186

870

1.96

16.33

1.4

—

(3028433) Virus identified in Specimen by Culture

259

2.83

16.27

1.2

—

(3000919) Neutrophils/100 leukocytes in Pleural fluid

348

2.55

16.17

1.4

24.9

21.5

0.49

316

(3043870) Heparin induced platelet Ab [Units/volume] in Serum

4.18

15.95

1.1

—

(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence

135

565

2.19

15.95

1.4

1.3

231.7

459.8

titre

0.67

(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay

158

704

2.06

15.89

1.2

1.1

96.6

94.7

0.35

153

655

(3014271) Vancomycin [Susceptibility]

135

566

2.19

15.88

3.2

3.0

—

(40768441) Liver Pathology biopsy report

144

624

2.12

15.59

1.5

1.3

—

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

201

985

1.87

15.38

1.2

154.4

196.6

miu/ml

0.85

301

(4306422)

193

934

1.90

15.35

1.2

—

(3050099) BK virus DNA [#/volume] (viral load) in Specimen by NAA with probe detection

10.27

15.35

3.4

4.6

—

(3045066) Thymidine kinase [Enzymatic activity/volume] in Serum

259

2.76

15.16

2.6

2.2

32.1

47.8

u/l

0.61

240

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

3552

28585

1.18

15.15

3.1

0.8

ug/l

0.23

2589

19817

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

234

2.85

15.15

1.2

1.1

—

(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence

130

548

2.17

15.11

1.4

1.3

65.0

63.9

titre

—

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

215

2.94

15.06

3.4

3.2

—

(3011985) Renin [Units/volume] in Plasma

214

1078

1.82

15.02

1.3

1.4

103.7

62.0

mu/l

1.47

183

949

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

156

3.28

14.74

1.5

1.6

—

(3020191) Ethanol [Moles/volume] in Serum or Plasma

153

694

2.02

14.70

1.5

1.3

1.5

1.3

promille

0.58

119

529

(46234826) Other cells/100 leukocytes in Peritoneal fluid by Manual count

4.70

14.60

2.7

2.0

5.0

18.0

2.75

(3006922) Hepatitis E virus Ab [Presence] in Serum

118

486

2.22

14.54

1.1

—

(4146454)

220

1132

1.78

14.42

3.0

2.7

—

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

112

455

2.25

14.27

1.1

—

(3020961) Endomysium IgA Ab [Titer] in Serum

419

2545

1.52

14.24

1.1

388.3

256.9

titre

—

(3027923) C peptide [Moles/volume] in Serum or Plasma

122

515

2.17

14.16

1.2

1.3

1.7

1.1

nmol/l

4.68

401

(3009871) Measles virus Ab [Titer] in Serum

165

3.16

14.12

1.6

1.5

—

(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis

4.02

14.12

4.8

5.8

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

424

2589

1.51

14.06

1.6

1.7

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

190

944

1.85

13.98

1.1

—

(3019977) pH of Arterial blood

133

584

2.09

13.97

3.1

2.6

7.4

0.11

199

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

111

454

2.24

13.93

1.1

—

(3023091) Interleukin 6 [Mass/volume] in Serum or Plasma

135

3.38

13.84

1.4

1.2

114.7

764.9

ng/l

0.58

(3016724) Homocysteine [Moles/volume] in Serum or Plasma

128

556

2.11

13.83

1.3

1.5

17.1

14.3

umol/l

3.09

116

526

(40758292) HTLV I+II Ab panel - Serum

118

3.56

13.75

1.5

—

(40761539) Cells [Type] in Urine sediment by Light microscopy

258

2.66

13.67

1.2

—

(3003752) BK virus DNA [Units/volume] (viral load) in Urine by NAA with probe detection

11.40

13.62

1.7

1.8

—

(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood

198

2.91

13.59

3.0

2.5

—

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

133

591

2.06

13.55

1.1

—

(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine

4.12

13.53

3.2

2.2

—

(3022689) Creatine [Moles/volume] in Urine

245

2.69

13.41

1.9

1.3

—

(3044242) Glucose [Moles/volume] in Arterial blood

119

509

2.14

13.39

2.1

2.0

—

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

363

2173

1.54

13.23

2.7

3.4

1631.8

604.2

u/ml

0.70

323

1974

(3029075) Extractable nuclear Ab panel - Serum

135

3.32

13.16

1.0

—

(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma

124

544

2.09

13.08

1.0

293.4

285.2

mg/l

0.54

109

488

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

456

2872

1.46

13.00

1.6

1.7

—

(40763641) Cell count and Differential panel - Peritoneal dialysis fluid

10.53

12.96

6.7

4.5

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

142

660

1.97

12.81

1.3

1.2

—

(3026051) Polymorphonuclear cells/100 leukocytes in Pleural fluid

294

2.49

12.79

1.5

1.3

23.3

21.2

0.23

241

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

385

2.28

12.66

1.2

1.3

—

(3017315) Amylase [Enzymatic activity/volume] in Urine

106

445

2.18

12.53

1.3

1.2

202.0

505.2

u/l

1.87

100

411

(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay

254

2.59

12.53

1.3

2.0

212.2

172.2

1.83

241

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

199

1038

1.76

12.52

1.2

1.3

0.2

0.3

nmol/l

0.15

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

259

1455

1.64

12.39

1.3

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

383

2.27

12.39

1.2

1.3

—

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

127

3.31

12.34

1.2

1.4

—

(3032390) JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection

10.64

12.16

1.7

1.3

—

(3026179) Normetanephrine [Moles/volume] in Serum or Plasma

198

1041

1.75

12.13

1.2

1.3

0.6

2.0

nmol/l

0.65

177

993

(3035509) Tobramycin [Mass/volume] in Serum or Plasma

102

3.58

12.10

2.6

3.2

1.6

1.1

mg/l

0.55

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

138

3.18

12.08

1.3

—

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

155

760

1.87

11.96

1.1

—

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

192

1009

1.75

11.80

1.3

1.4

301.9

254.9

pmol/l

0.97

148

740

(3039443) Prostate specific Ag panel - Serum or Plasma

141

2331

0.55

11.60

1.6

1.7

—

(3001850) Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay

114

3.37

11.59

1.1

1.2

82.7

79.5

0.18

(3052592) Norovirus Ag [Presence] in Stool

201

2.73

11.57

1.5

1.4

—

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

101

3.53

11.55

1.1

—

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

249

1414

1.62

11.44

1.1

—

(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay

115

3.34

11.44

1.1

1.2

77.5

70.5

0.44

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

201

1085

1.70

11.24

1.6

1.5

—

(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid

367

2.22

11.05

1.3

3.4

166.6

ug/l

3.84

204

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

191

2.73

11.01

1.2

—

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

5.12

10.90

1.1

—

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

326

1995

1.50

10.79

2.2

1.5

1.1

0.8

nmol/l

8.69

265

1650

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

1038

7631

1.26

10.74

1.6

1.5

—

(3008037) Lactate [Moles/volume] in Venous blood

407

2610

1.44

10.62

5.0

3.2

1.7

mmol/l

0.13

396

2557

(3006576) Bicarbonate [Moles/volume] in Blood

416

2.11

10.56

8.1

6.7

24.4

25.0

mmol/l

0.65

375

(3020491) Glucose [Moles/volume] in Blood

126

603

1.91

10.53

2.7

1.9

7.5

7.1

mmol/l

0.46

405

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

181

968

1.71

10.51

1.2

1.3

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

1469

11270

1.21

10.19

14.7

7.6

—

(3011436) Histone Ab [Units/volume] in Serum

110

3.24

10.17

1.1

1.0

—

u/ml

—

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

345

2.20

10.15

1.2

1.5

5.4

7.0

u/l

1.36

279

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

212

2.54

9.98

1.2

—

(43055458) Rivaroxaban [Mass/volume] in Serum or Plasma

107

3.24

9.95

1.4

1.2

95.5

105.6

ug/l

0.18

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

325

2.22

9.91

1.2

1.1

ratio

0.20

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

147

755

1.78

9.85

1.3

1.5

—

(40757373) Influenza virus identified in Isolate

219

2.50

9.83

1.3

1.8

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

143

737

1.78

9.49

1.3

1.2

—

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

101

3.25

9.49

1.8

1.5

—

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

1403

10788

1.21

9.49

5.6

4.7

31.0

32.4

4.75

1034

7035

(4281824)

142

731

1.78

9.47

1.4

1.2

—

(3043681) Transitional cells [#/area] in Urine by Computer assisted method

4.15

9.29

1.1

1.0

1.2

u/field

0.66

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

146

2.82

9.29

1.3

1.5

11.8

9.2

ug/l

2.13

146

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

169

921

1.68

9.22

1.2

1.3

—

nmol/l

—

(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma

189

2.56

9.14

1.1

1.3

0.3

g/l

1.25

152

(3023383) Lactate [Moles/volume] in Pleural fluid

393

2.05

9.01

1.5

1.3

2.6

3.7

mmol/l

3.76

361

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

315

2.18

8.99

1.0

1.1

—

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

159

2.70

8.99

1.1

1.2

67.6

76.4

0.69

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

149

2.76

8.96

1.2

1.1

—

(40771901) t(9;22)(q34.1;q11)(ABL1,BCR) b2a2+b3a2 fusion transcript/control transcript (International Scale) [# Ratio] in Blood or Tissue by Molecular genetics method

4.46

8.95

12.7

7.7

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

151

806

1.72

8.90

1.3

—

(3041918) Cholesterol [Moles/volume] in Pleural fluid

208

2.46

8.89

1.3

1.2

1.3

1.5

mmol/l

0.71

128

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

166

2.64

8.81

1.1

68.6

82.5

2.11

(3011544) Albumin [Mass/volume] in Pleural fluid

111

3.04

8.77

1.1

1.2

13.9

17.2

g/l

1.61

101

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

3.73

8.74

1.2

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

236

1414

1.53

8.72

1.1

—

(21493619) Chromosome 12 trisomy and chromosome region 11q22.3 and 13q14 and 17p13.1 deletion in Blood or Tissue by FISH

4.20

8.69

1.2

1.3

—

(3032057) Clostridioides difficile [Presence] in Stool

200

2.47

8.63

2.6

1.9

—

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

105

507

1.89

8.63

1.9

1.8

3.2

2.9

u/field

0.08

351

(1761868) Lipid panel - Serum or Plasma

2645

26828

0.87

8.62

3.7

3.2

—

(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection

5.13

8.57

1.4

1.5

—

(3006653) Thiamine [Moles/volume] in Blood

376

2.04

8.57

1.2

1.1

149.8

135.5

nmol/l

1.18

376

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

557

3895

1.32

8.56

2.7

3.5

940.6

2577.0

u/ml

1.20

478

3399

(3028772) Osteocalcin [Mass/volume] in Serum or Plasma

389

2.02

8.53

2.6

—

35.4

—

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

261

1609

1.49

8.44

1.4

1.3

4.1

3.9

mmol/l

0.87

246

1508

(4024509)

127

656

1.77

8.42

2.0

1.6

—

(3028029) Mesothelial cells/100 leukocytes in Pleural fluid

197

2.46

8.42

1.4

6.8

8.7

0.29

101

(3000330) Specific gravity of Urine by Test strip

682

4918

1.28

8.31

5.0

3.6

—

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

320

2.11

8.28

3.6

2.3

—

(3019174) dRVVT (LA screen)

4.69

8.19

1.2

1.1

—

(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method

3.60

8.00

7.8

3.5

—

(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification

289

2.15

7.97

4.8

9.3

45.0

1439.8

u/ml

—

103

(3034274) Bile acid [Moles/volume] in Serum --fasting

279

2.16

7.84

1.9

1.6

19.6

14.6

umol/l

0.25

201

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

290

1854

1.44

7.81

1.5

1.3

660.4

545.4

mg/l

2.29

278

1754

(3018851) Theophylline [Moles/volume] in Serum or Plasma

100

3.01

7.73

1.7

1.6

53.8

43.7

umol/l

0.90

100

(44786800) Granulocytes/100 leukocytes in Body fluid

167

2.52

7.71

1.5

1.3

16.0

24.2

1.01

136

(3035999) Lactate [Moles/volume] in Cerebral spinal fluid

110

561

1.79

7.66

1.2

1.3

2.3

2.2

mmol/l

0.24

104

519

(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method

3.15

7.56

1.1

—

(3051593) INR in Capillary blood by Coagulation assay

115

599

1.76

7.47

7.8

11.9

—

(46236287) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Pleural fluid by Immunoassay

4.15

7.46

1.2

1.3

7828.8

2146.1

ng/l

0.55

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

285

2.12

7.46

9.2

8.2

—

(3009214) Lutropin [Units/volume] in Serum or Plasma

256

1616

1.45

7.40

1.5

1.3

9.1

8.9

u/l

0.10

199

1278

(3001964) Herpes simplex virus Ag [Presence] in Specimen

234

2.23

7.30

1.5

1.7

—

(3044290) Cell count panel - Cerebral spinal fluid

242

1516

1.46

7.29

1.5

1.4

—

(3023659) Complement C1 esterase inhibitor.functional/Complement C1 esterase inhibitor.total in Serum or Plasma

183

2.40

7.28

1.1

1.3

115.2

115.0

0.01

170

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

242

1519

1.46

7.22

1.1

12.4

10.3

u/ml

0.15

158

(3002568) Complement factor B [Mass/volume] in Serum or Plasma

16.72

7.21

1.1

1.2

0.2

g/l

—

(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum

259

2.15

7.20

1.2

1.1

17.6

16.8

u/ml

—

(3014891) Appearance of Pleural fluid

196

2.33

7.14

2.0

1.6

—

(4034850)

405

2781

1.34

7.12

19.3

10.8

—

(4212803)

101

2.89

7.02

1.2

1.1

—

(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy

4.03

6.85

1.2

1.1

—

(3011335) Digoxin [Mass/volume] in Serum or Plasma

2.89

6.79

2.6

2.5

—

(3008295) Osmolality of Serum or Plasma

155

903

1.57

6.61

1.4

1.3

281.4

278.2

mosm/kgh2o

0.72

119

689

(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma

3.01

6.58

1.1

1.2

—

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

164

2.39

6.55

1.2

1.3

—

(43055246) Days in therapeutic INR range/Days INR result determined [Ratio]

295

2.01

6.49

4.3

5.6

68.9

71.1

0.27

235

(3007302) Hemoglobin [Mass/volume] in Mixed venous blood

4.42

6.47

14.5

10.7

—

(3043410) Blood group antigens tested for on Red Blood Cells

253

2.09

6.44

2.0

—

(3038515) Glucose [Moles/volume] in Venous blood

364

2503

1.33

6.39

5.4

3.3

7.6

8.0

mmol/l

1.69

354

2457

(3044009) aPTT.lupus sensitive (LA screen)

3.91

6.25

1.2

1.1

—

(37021550) Renin [Units/volume] in Plasma --upright

168

2.34

6.23

1.3

117.6

75.3

mu/l

0.62

130

(3035320) C reactive protein [Mass/volume] in Body fluid

101

536

1.72

6.22

3.3

2.3

—

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

214

1357

1.44

6.12

1.1

24.4

241.2

iu/ml

0.79

256

(3042010) Triglyceride [Moles/volume] in Pleural fluid

165

2.32

6.02

1.3

1.2

0.8

1.1

mmol/l

0.29

109

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

143

2.43

5.99

1.1

—

(46236302) HLA-C [Type] by High resolution typing

4.94

5.95

1.0

—

(40763590) HLA-DQ beta [Type]

4.94

5.95

1.0

—

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

512

1.71

5.84

1.3

2.2

673.2

1307.1

u/l

0.37

161

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

246

1615

1.40

5.82

1.6

1.5

1111.2

2915.2

e6/l

0.63

202

1316

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

246

1615

1.40

5.82

1.5

1.4

75.9

23.2

e6/l

0.55

189

1258

(3038071) Oxygen [Partial pressure] in Mixed venous blood

245

2.05

5.82

9.3

8.2

—

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

419

1.79

5.79

1.1

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

290

1.95

5.74

1.3

1.4

—

(3040491) Angiotensin converting enzyme [Enzymatic activity/volume] in Pleural fluid

114

2.56

5.66

1.1

19.7

17.2

u/l

0.39

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

293

1990

1.35

5.64

1.3

1.2

—

(3015401) Amylase [Enzymatic activity/volume] in Pleural fluid

153

2.33

5.63

1.3

1.2

1088.9

102.9

u/l

0.44

105

(3028714) Urate [Moles/time] in 24 hour Urine

6.08

5.61

1.1

—

(3032352) Blasts [#/volume] in Cerebral spinal fluid

2.72

5.55

2.6

1.9

—

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

201

2.14

5.54

1.1

—

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

160

2.28

5.53

1.3

1.1

—

(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright

196

2.14

5.48

1.2

404.0

269.4

pmol/l

0.69

147

(3013293) Extractable nuclear Ab [Presence] in Serum

3.00

5.42

1.3

1.7

—

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

416

1.76

5.35

1.1

—

(3016244) Insulin [Units/volume] in Serum or Plasma

223

2.05

5.31

2.6

3.0

35.7

27.0

mu/l

0.62

206

(3016038) Potassium [Moles/volume] in Urine

109

620

1.61

5.23

1.1

34.9

35.2

mmol/l

0.05

518

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

3.91

5.23

1.1

—

(3016018) Differential panel - Cerebral spinal fluid

131

783

1.53

5.09

1.4

—

(40760409) HLA-A [Type] by High resolution

4.56

5.03

1.0

—

(40760410) HLA-B [Type] by High resolution

4.56

5.03

1.0

—

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

185

2.12

5.03

1.1

—

(3016628) Fibrinogen Ag [Mass/volume] in Platelet poor plasma by Immunoassay

156

2.22

4.98

1.3

1.2

0.9

69.6

mg/l

1.00

119

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

235

1.98

4.98

2.5

2.3

—

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

360

1.78

4.90

1.1

1.0

—

(4015189)

282

1.88

4.86

1.8

2.1

—

(3028707) Methadone [Presence] in Urine by Screen method

527

1.63

4.82

1.8

2.8

—

(3013862) HLA-DP [Type]

4.38

4.81

1.0

—

(3035637) Corticotropin [Mass/volume] in Plasma

156

980

1.46

4.79

1.5

—

(3035285) Chloride [Moles/volume] in Venous blood

228

1536

1.36

4.70

4.0

2.4

105.4

mmol/l

0.07

228

1520

(3041354) Potassium [Moles/volume] in Venous blood

228

1536

1.36

4.70

4.0

2.4

4.2

4.1

mmol/l

2.07

228

1520

(3017937) Magnesium [Moles/time] in 24 hour Urine

4.56

4.61

1.5

1.2

—

(3005011) Chlamydia sp Ab [Titer] in Serum

2.86

4.60

1.6

1.8

—

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

121

2.34

4.59

1.2

1.0

—

(1002224) Polysomnography panel

355

2554

1.27

4.58

1.1

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

243

1.92

4.56

1.4

1.3

—

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

117

2.34

4.45

1.2

1.1

—

(3022411) Androstenedione [Moles/volume] in Serum or Plasma

4.80

4.43

1.5

1.9

41.8

2.9

nmol/l

—

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

285

2004

1.30

4.40

1.6

—

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

332

1.76

4.39

1.1

—

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

422

1.67

4.35

1.7

1.8

—

(3033705) Calcium.ionized [Moles/volume] in Venous blood

223

1517

1.35

4.35

4.0

2.4

—

(3027318) Ethylene glycol [Moles/volume] in Serum or Plasma

4.18

4.17

1.3

1.1

—

mmol/l

—

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

115

2.30

4.17

2.0

2.3

—

(3006270) Folate [Moles/volume] in Blood

125

775

1.47

4.16

1.3

1.2

290.8

334.9

nmol/l

1.61

600

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

442

1.63

4.14

1.3

1.6

—

(3020393) Adenovirus Ag [Presence] in Stool

2.45

4.12

1.2

1.1

—

(3001019) Free T4 and TSH panel - Serum or Plasma

162

2033

0.72

4.08

1.4

1.6

—

(3013637) Mi-2 Ab [Presence] in Serum

159

2.07

4.01

1.0

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

159

2.07

4.01

1.0

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

159

2.07

4.01

1.0

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

159

2.07

4.01

1.0

—

(3003985) Beta hydroxybutyrate [Moles/volume] in Serum or Plasma

2.50

3.95

1.5

1.9

0.2

1.1

mmol/l

2.70

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

118

2.24

3.95

2.0

2.2

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

323

1.72

3.94

3.6

2.5

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

323

1.72

3.94

3.6

2.5

—

(3024316) Viscosity of Plasma

3.18

3.94

2.1

2.3

1.8

2.0

mpas

—

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

211

1.90

3.91

1.1

—

(44813793)

347

1.68

3.81

1.0

—

(3028717) Thiamine [Mass/volume] in Blood

2.55

3.78

1.2

1.1

—

(44786774) Adalimumab [Mass/volume] in Serum or Plasma

2.44

3.78

1.7

2.1

7.3

8.0

mg/l

0.25

(3001820) Epstein Barr virus nuclear Ab [Presence] in Serum

5.86

3.70

1.0

1.1

—

(3033306) Mononuclear cells/100 leukocytes in Cerebral spinal fluid

330

1.69

3.68

1.2

43.4

57.5

0.61

(3015956) Eosinophils/100 leukocytes in Blood by Manual count

3.53

3.67

1.7

1.3

2.8

2.1

0.23

(3013139) Helicobacter pylori Ag [Presence] in Stool

596

4636

1.18

3.66

1.2

—

(3003129) Base excess in Capillary blood by calculation

270

1.76

3.62

1.5

1.8

-0.1

0.4

mmol/l

0.27

251

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

117

2.18

3.61

1.1

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

381

2851

1.22

3.56

1.1

—

(44806071)

2.46

3.51

1.1

—

(3044416) Complement C4 [Mass/volume] in Pleural fluid

2.91

3.43

1.0

1.3

0.1

g/l

—

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

2.31

3.37

1.0

—

(3004905) Lipase [Enzymatic activity/volume] in Serum or Plasma

164

1.95

3.37

4.1

5.0

46.2

77.5

u/l

0.65

(3000081) cloZAPine [Moles/volume] in Serum or Plasma

468

0.49

3.36

19.0

17.4

1525.5

1383.2

nmol/l

0.37

447

(3042552) Rheumatoid factor [Units/volume] in Pleural fluid

2.39

3.34

1.1

1.0

14.0

11.6

iu/ml

—

(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma

146

2.00

3.32

1.6

1.5

0.4

ug/l

0.14

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

140

2.02

3.31

1.2

1.1

—

(3032185) JC virus DNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection

9.12

3.29

3.8

1.7

—

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

258

1869

1.26

3.26

2.0

1.8

185.5

199.4

pmol/l

1.30

232

1754

(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma

552

1.49

3.25

2.4

1.5

0.9

g/l

0.20

547

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

280

1.70

3.23

1.1

10.5

9.1

iu/ml

—

(3008832) Norclozapine [Moles/volume] in Serum or Plasma

448

0.49

3.21

14.2

12.6

859.4

825.6

nmol/l

0.11

425

(4198724)

180

1.88

3.21

1.3

2.7

—

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

127

834

1.39

3.20

2.0

2.1

1.8

2.1

u/field

0.24

297

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

200

1.83

3.19

1.1

—

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

138

1.98

3.07

2.2

2.3

—

(3039114) Acanthocytes/1000 erythrocytes in Blood by Light microscopy

7.81

3.06

1.0

1.3

—

(3031067) HIV 1 p24 Ag [Mass/volume] in Serum or Plasma by Immunoassay

3.24

2.99

1.0

—

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

121

2.04

2.97

1.4

1.1

—

(3027570) Oxalate [Moles/time] in 24 hour Urine

2.63

2.90

1.5

1.2

335.5

328.4

umol/24h

0.05

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

456

3545

1.18

2.90

1.2

1.1

114.6

126.9

iu/ml

0.25

128

1184

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

207

1.76

2.89

1.0

1.1

—

(3017446) Testosterone [Moles/volume] in Serum or Plasma

1045

8606

1.12

2.86

2.3

2.1

10.8

12.6

nmol/l

7.70

870

7534

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

228

1.72

2.86

1.3

1.5

—

(3011288) Drugs identified in Urine by Screen method

111

728

1.39

2.86

2.6

3.0

—

(3006462) Nitrate [Presence] in Urine

392

1.54

2.82

5.4

3.0

—

(3034426) Prothrombin time (PT)

236

1.70

2.82

1.3

1.2

—

(3018133) Calcium [Moles/volume] in Urine

2.20

2.81

1.3

1.8

2.0

2.5

mmol/l

0.38

(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay

4.56

2.81

1.3

1.1

—

(4211845)

430

1.51

2.78

5.2

2.9

—

(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)

300

1.61

2.78

1.4

1.6

3.2

14.1

nmol/l

0.78

260

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

380

1.54

2.75

1.2

1.3

1.7

u/ml

0.13

220

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

2.14

2.74

1.0

—

(3016284) Epstein Barr virus nuclear Ab [Units/volume] in Serum

6.08

2.67

1.2

1.1

—

(3024869) Neuronal Ab [Presence] in Serum

159

1.84

2.66

1.1

—

(40762887) Creatinine [Moles/volume] in Blood

4.91

2.65

1.1

1.3

—

(3041184) Isoniazid [Presence] in Urine

4.91

2.65

2.6

3.0

—

(3005570) Glucose [Moles/volume] in Urine

130

888

1.34

2.63

2.0

1.7

—

1.2

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

130

889

1.34

2.61

1.9

2.2

—

(3008116) Ketones [Moles/volume] in Urine by Test strip

174

1.78

2.58

1.4

1.3

—

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

2.15

2.54

1.1

—

(3046861) Legionella sp Ag [Presence] in Urine

2.44

2.53

1.0

1.1

—

(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay

2.44

2.53

1.1

1.2

—

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

123

1.93

2.51

1.0

1.2

—

(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma

225

1663

1.24

2.48

1.6

1.9

19.4

25.4

ug/l

1.71

220

1621

(3027974) Hepatitis B virus e Ag [Presence] in Serum

3.04

2.48

1.1

1.5

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

972

0.70

2.45

1.7

1.3

—

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

406

1.48

2.44

1.1

3.6

8.8

nmol/l

0.63

(3021387) Prolactin [Units/volume] in Serum or Plasma

184

1333

1.26

2.43

1.6

1.8

320.0

293.7

mu/l

0.39

159

1246

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

146

0.31

2.42

1.8

1.5

—

(3014702) Chromogranin A [Moles/volume] in Serum or Plasma

162

1160

1.28

2.36

3.5

3.7

5.6

8.0

nmol/l

1.39

156

1136

(3019298) Eosinophils/100 leukocytes in Peritoneal fluid

2.94

2.36

1.9

1.4

0.4

—

(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay

256

1.60

2.36

1.0

1.1

98.7

96.6

0.16

197

(3028679) Herpes simplex virus Ab [Presence] in Serum

286

1.56

2.32

1.1

—

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

294

2252

1.19

2.29

3.6

4.1

56.7

94.5

u/ml

1.25

283

2166

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

181

1.71

2.29

1.5

1.4

—

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

375

1.48

2.28

1.1

—

(3011325) HIV 1+2 Ab [Presence] in Serum

2.85

2.24

1.0

—

(3030313) Adrenal Ab [Titer] in Serum

3.47

2.23

1.0

—

(3018291) Platelet Ab [Presence] in Serum

4.56

2.22

1.3

1.0

—

(3041678) Intrinsic coagulation system thromboelastography panel - Blood

2.42

2.17

1.1

1.3

—

(3050794) Legionella sp Ab [Presence] in Serum

2.04

2.16

1.1

—

(3032333) Phosphate [Mass or Moles] in 24 hour Urine

3.75

2.15

1.0

1.1

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

206

1.64

2.14

1.4

—

(3013945) Hepatitis B virus e Ab [Presence] in Serum

2.76

2.14

1.1

1.4

—

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

773

0.69

2.10

1.7

1.3

53.2

70.3

pmol/l

0.64

229

(1617658) Protocol used for examination of sentinel lymph nodes

408

0.58

2.09

1.1

—

(3035933) Granulocytes/100 leukocytes in Blood

139

1.77

2.06

1.8

1.5

—

(3010370) Gastrin [Moles/volume] in Serum or Plasma

119

1.84

2.06

1.0

1.6

69.3

57.7

pmol/l

0.19

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

209

1.62

2.03

1.1

—

(4133840)

174

1.68

2.03

1.2

—

(40768793) Breast Pathology biopsy report

1102

0.75

2.00

1.2

1.3

—

(3042585) Pyridoxine [Moles/volume] in Serum or Plasma

210

1.61

2.00

1.3

123.1

126.4

nmol/l

0.04

147

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

203

1.62

2.00

1.1

—

(3023410) Appearance of Cerebral spinal fluid

101

699

1.32

1.96

1.9

1.6

—

(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum

3.36

1.95

1.0

1.2

—

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

1.90

1.1

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

462

4749

0.88

1.90

1.4

—

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

195

2143

0.83

1.90

2.1

1.7

5.9

3.7

mg/l

1.53

171

1490

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

304

0.54

1.90

1.4

—

(3015183) Erythrocyte sedimentation rate

235

1.55

1.89

1.2

—

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

197

1486

1.21

1.87

1.6

5.1

4.4

iu/l

0.27

472

(3032743) Legionella sp IgG Ab [Presence] in Serum

2.10

1.87

1.1

—

(3015822) Parvovirus B19 DNA [Presence] in Serum by NAA with probe detection

3.19

1.86

1.0

1.1

—

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

118

1.78

1.80

1.9

1.6

—

(3020123) Porphyrins [Interpretation] in Serum or Plasma

2.81

1.80

1.4

1.0

—

(3017461) Flecainide [Moles/volume] in Serum or Plasma

2.20

1.79

1.4

1.5

0.8

0.7

umol/l

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

203

1.57

1.77

1.1

—

(3030862) Granulocytes [#/volume] in Cerebral spinal fluid

218

1.55

1.75

1.2

48.4

23.3

—

(21494567) Legionella sp IgM Ab [Presence] in Serum

2.04

1.74

1.1

—

(3043649) Fibrin monomer [Presence] in Platelet poor plasma by Hemagglutination

2.70

1.73

1.1

1.0

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

279

1.47

1.70

1.0

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

145

1073

1.23

1.69

1.3

—

(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum

2.90

1.69

1.0

1.1

—

(40760435) Tropomyosin IgE Ab [Units/volume] in Serum

2.40

1.67

1.0

1.1

—

(3035510) Gentamicin [Mass/volume] in Serum or Plasma

2.60

1.66

8.1

7.0

1.3

0.9

mg/l

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

135

0.40

1.64

1.7

1.4

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

135

0.40

1.64

1.8

1.4

—

(3016879) Cocaine [Presence] in Urine

147

1094

1.23

1.64

1.9

2.1

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

136

0.40

1.64

1.8

1.4

—

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

136

0.40

1.64

1.8

1.4

—

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

193

1.56

1.63

1.0

1.1

—

(3025886) Oxalate [Mass/time] in 24 hour Urine

3.04

1.58

1.0

1.1

—

(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma

327

2616

1.14

1.58

1.9

1.6

36.6

44.6

nmol/l

8.86

312

2520

(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing

1.95

1.57

1.4

1.1

—

(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline

330

1.41

1.56

1.1

1.2

6.3

6.2

mmol/l

0.08

311

(1761482) Bacteria [#/volume] in Urine by Culture

373

3013

1.13

1.56

5.3

4.1

—

(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method

1.96

1.50

1.0

1.6

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

117

0.39

1.49

1.8

1.5

—

(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum

2.49

1.49

1.1

1.0

—

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

1.82

1.48

1.1

—

(3001501) Glucose [Moles/volume] in Capillary blood by Glucometer

213

1.50

1.47

3.7

2.6

7.9

7.8

mmol/l

0.07

123

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

127

1.65

1.45

1.0

1.2

—

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

120

1.67

1.45

3.2

2.6

0.4

u/field

0.08

120

(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method

2.22

1.44

1.0

1.1

—

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

398

1.35

1.44

1.0

1.1

456.1

339.8

mg/l

0.95

346

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

215

1.49

1.42

1.1

—

(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal

646

1.27

1.42

1.1

1.2

12.1

12.0

mmol/l

0.07

220

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

409

0.67

1.41

1.0

0.0

0.7

u/ml

—

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

376

1.36

1.41

1.3

1.4

0.2

nmol/l

0.16

280

(3016273) Islet cell 512 Ab [Units/volume] in Serum

2.28

1.41

1.0

—

(3050129) First trimester maternal screen panel - Serum or Plasma

163

0.50

1.40

1.7

1.5

—

(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma

369

1.36

1.39

2.1

2.5

64.9

56.2

umol/l

0.70

315

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

698

1.26

1.37

1.1

9.6

3.5

u/ml

0.48

261

(3005033) Fetal Nuchal fold Thickness US

113

0.40

1.37

1.8

1.4

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

114

0.40

1.36

1.8

1.4

—

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

212

1.46

1.30

1.0

1.1

—

(44806420)

382

1.34

1.30

2.5

2.4

—

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

423

1.32

1.27

1.0

1.2

56.2

49.3

mg/l

0.42

354

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

1.69

1.26

1.5

1.3

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

1.69

1.26

1.5

1.3

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

1.69

1.26

1.5

1.3

—

(3000764) Benzodiazepines [Presence] in Urine

151

1163

1.19

1.25

1.9

2.1

—

(36303858) Crystals [Presence] in Urine

2.68

1.22

1.0

1.1

—

(3002523) Influenza virus A Ag [Presence] in Specimen

695

1.23

1.19

1.1

—

(3014133) Dog dander IgE Ab [Units/volume] in Serum

496

0.73

1.15

1.1

1.0

6.3

2.4

u/ml

0.60

188

(3003740) Influenza virus B Ag [Presence] in Specimen

700

1.23

1.13

1.1

—

(3012494) Peanut IgE Ab [Units/volume] in Serum

108

1.60

1.11

1.0

0.4

u/ml

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

628

1.24

1.11

2.2

1.9

—

(3027008) Opiates [Presence] in Urine

150

1171

1.17

1.10

1.9

—

(3016616) Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Serum or Plasma

160

1.48

1.09

1.0

1.1

2.9

3.1

umol/l

0.16

144

(40757578) FLT3 gene targeted mutation analysis in Bone marrow by Molecular genetics method

2.20

1.08

1.0

1.1

—

(3009466) Valproate [Moles/volume] in Serum or Plasma

173

1368

1.15

1.08

5.2

4.7

337.5

352.5

umol/l

0.77

145

1152

(3028300) Cannabinoids [Presence] in Urine

150

1174

1.17

1.07

1.9

2.1

—

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

1.63

1.07

1.0

1.1

—

(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma

885

0.81

1.06

2.9

3.7

35.1

42.0

u/ml

0.25

851

(4027681)

301

1.33

1.05

1.3

—

(3033923) Metanephrine [Moles/time] in 24 hour Urine

147

1.49

1.04

1.2

1.1

0.5

0.7

umol/24h

—

(3027944) Amphetamines [Presence] in Urine

146

1146

1.16

1.02

2.0

—

(3051101) Glucose [Moles/volume] in Cord blood

240

0.65

1.01

5.0

6.5

—

(3033086) Enterovirus NOS Ab [Titer] in Serum

2.28

0.94

1.0

—

(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma

462

1.24

0.92

1.4

1.9

16.7

15.7

nmol/l

0.38

429

(3014599) Egg white IgE Ab [Units/volume] in Serum

223

0.65

0.91

1.0

0.4

0.6

u/ml

—

(3042299) inFLIXimab [Mass/volume] in Serum or Plasma

116

1.49

0.86

3.1

3.2

6.3

7.5

mg/l

0.26

(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay

1.95

0.85

1.0

1.1

—

(3051339) Copper [Moles/volume] in Blood

1.95

0.85

1.0

1.1

17.8

17.1

umol/l

—

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

394

1.25

0.84

1.0

1.1

—

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

1.62

0.83

1.2

—

(3003888) Timothy IgE Ab [Units/volume] in Serum

709

0.82

0.83

1.1

1.0

2.7

4.5

u/ml

0.76

321

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

428

1.24

0.82

1.3

24.9

27.4

u/l

0.19

356

(3025443) Phadiatop IgE Ab [Units/volume] in Serum

242

1.32

0.82

1.1

9.1

7.1

u/ml

—

(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma

1.58

0.80

1.1

1.4

—

(3023323) Follitropin [Units/volume] in Serum or Plasma

130

1037

1.14

0.78

1.5

1.3

25.6

29.4

iu/l

0.54

848

(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen

0.52

0.78

6.0

6.1

—

(40761995) Spermatozoa Progressive [#/volume] in Semen

0.51

0.78

3.0

—

(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid

1.67

0.78

1.0

—

(3010726) Horse dander IgE Ab [Units/volume] in Serum

603

0.82

0.77

1.1

1.0

1.2

1.5

u/ml

—

136

(3045519) Venlafaxine [Moles/volume] in Serum or Plasma

2.17

0.76

1.0

1.4

606.4

604.7

nmol/l

—

(40758358) Immune stain study

1.76

0.76

1.0

—

(3023430) Cat dander IgE Ab [Units/volume] in Serum

461

0.79

0.76

1.1

1.0

3.1

3.8

u/ml

0.16

169

(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.61

0.75

1.0

1.1

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

222

1.31

0.75

1.1

1.2

—

(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma

1.69

0.74

2.6

2.3

—

(3018980) carBAMazepine [Moles/volume] in Serum or Plasma

347

0.76

0.73

2.9

33.3

29.4

umol/l

1.19

260

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

797

0.85

0.73

1.1

2.4

1.2

u/ml

0.47

318

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

1.56

0.72

1.4

—

(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma

1.61

0.72

1.2

1.0

—

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

176

1.35

0.72

1.1

1.2

—

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood

200

1.32

0.71

6.2

7.9

—

(3019768) Coxiella burnetii Ab [Presence] in Serum

1.58

0.71

1.0

1.3

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

281

1.27

0.70

1.2

1.1

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

614

1.17

0.69

1.0

1.1

—

(3034092) Cytoplasmic Ig cells/100 cells in Blood

107

0.60

0.68

34.6

9.8

—

(3042951) Complement C1q Ab [Units/volume] in Serum

1.82

0.67

1.0

1.2

—

21.5

—

(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

1.59

0.67

1.6

1.1

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

1.48

0.65

2.2

1.6

—

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

109

1.42

0.64

1.0

1.1

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

119

0.61

0.63

1.6

—

(3049242) von Willebrand panel - Platelet poor plasma

1.69

0.62

2.4

1.4

—

(3008401) Mugwort IgE Ab [Units/volume] in Serum

684

0.85

0.61

1.1

1.0

0.5

1.4

u/ml

1.68

274

(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid

304

1.23

0.60

1.0

1.2

621.3

593.6

ng/l

0.02

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

142

1.35

0.60

1.4

1.2

—

(3009677) Dengue virus Ab [Presence] in Serum

0.00

0.60

0.0

1.2

—

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

119

1.38

0.59

1.5

3.5

—

(3007625) Streptococcus pneumoniae Ag [Presence] in Specimen

1.66

0.56

2.5

1.8

—

(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection

1.61

0.55

1.3

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

118

966

1.11

0.54

1.9

2.0

—

(3016426) Methylmalonate [Moles/volume] in Serum or Plasma

1.56

0.53

1.3

1.1

252.8

238.0

nmol/l

—

(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis

1.47

0.53

1.2

—

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

1.44

0.52

1.0

—

(3000285) Sodium [Moles/volume] in Blood

146

1.31

0.52

1.1

1.2

—

(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

122

0.67

0.52

1.0

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

779

1.12

0.51

1.9

2.1

—

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

699

0.87

0.50

1.0

38.1

42.7

ng/l

0.55

476

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

698

0.87

0.49

1.0

729.8

697.9

ng/l

0.23

465

(40763480) Human metapneumovirus Ag [Presence] in Specimen

1.56

0.49

2.3

1.6

—

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

1.45

0.48

1.2

1.1

—

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

550

0.86

0.47

4.5

5.7

45.2

57.2

u/ml

0.13

163

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

101

1.35

0.46

1.0

1.1

—

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

694

0.88

0.46

1.0

279.2

324.9

ng/l

1.10

480

(3051387) C reactive protein [Mass/volume] in Capillary blood

224

2185

0.93

0.46

5.5

3.4

30.2

30.8

mg/l

0.11

157

1454

(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid

1.39

0.44

1.0

—

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

117

0.70

0.43

1.2

1.6

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

309

0.83

0.42

1.1

—

(3044336) Cobalt [Moles/volume] in Urine

0.00

0.41

0.0

2.1

—

18.5

—

(3020874) Milk IgE Ab [Units/volume] in Serum

228

0.80

0.41

1.0

0.3

0.6

u/ml

—

(40768800) Prostate Pathology biopsy report

363

3466

0.95

0.39

1.2

—

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

137

1.26

0.39

1.5

1.2

—

(3020650) Glucose [Presence] in Urine

187

1.22

0.38

1.4

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

147

1.24

0.36

1.0

1.1

—

(40761516) BRAF gene p.Val600Glu [Presence] in Tissue by Molecular genetics method

0.65

0.36

1.0

—

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

139

1.25

0.35

1.3

2.2

—

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

427

0.87

0.34

5.8

6.9

—

(43055514) Macroprolactin [Presence] in Serum or Plasma

1.29

0.29

1.0

1.5

—

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

834

1.07

0.26

1.2

8.3

7.7

mmol/l

0.89

583

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

1.27

0.24

1.6

1.9

23.8

17.8

umol/l

0.79

(3017414) Tyrophagus putrescentiae IgE Ab [Units/volume] in Serum

0.00

0.21

0.0

1.0

—

0.2

—

(3040794) Aluminum [Moles/volume] in Urine

0.00

0.21

0.0

1.0

—

(4094501)

270

2395

1.03

0.16

1.1

—

(21491866) Provasopressin.C-terminal [Moles/volume] in Serum or Plasma by Immunoassay

0.75

0.15

1.8

1.2

20.0

23.8

pmol/l

—

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

1.12

0.15

1.1

1.0

—

(40765089) Chromosome analysis panel - Blood by G-banded

1.15

0.11

1.1

1.0

—

(40761872) Peanut recombinant (rAra h) 2 IgE Ab [Units/volume] in Serum

1.11

0.10

1.0

0.0

0.1

u/ml

—

(3023511) Choriogonadotropin [Units/volume] in Urine

150

1.09

0.09

1.3

—

(3016184) Myelin associated glycoprotein Ab [Units/volume] in Serum

1.06

0.08

1.0

1.6

—

29818.0

—

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

100

1.09

0.05

1.0

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

386

3492

1.01

0.04

1.3

1.2

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

299

1.04

0.04

1.1

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

634

1.02

0.04

1.3

1.4

—

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

1.09

0.03

2.1

2.0

—

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

135

1.01

0.00

1.1

1.7

—

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

332

0.99

0.00

1.1

1.0

1.2

u/l

0.66

167

(3025130) Human papilloma virus identified in Specimen

342

0.99

0.00

1.9

1.6

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

306

1.01

0.00

1.3

1.5

—

(3013336) Amino acids [Identifier] in Serum or Plasma

0.00

0.0

5.8

—

(3002079) Sodium [Moles/time] in 24 hour Urine

0.00

0.0

1.0

—

126.9

—

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

0.96

0.00

1.1

1.0

—

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

1.01

0.00

1.1

1.8

umol/24h

—

(3014178) Parietal cell Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(3007463) Buprenorphine [Presence] in Urine

0.00

0.0

9.0

—

(21494671) JAK2 gene exon 14 targeted mutation analysis in Bone marrow by Molecular genetics method

0.00

0.0

1.0

—

(3037377) Propoxyphene + Norpropoxyphene [Presence] in Urine by Confirmatory method

0.00

0.0

1.0

—

(3036180) Methadone [Presence] in Urine

0.00

0.0

3.0

—

(3017986) Aspergillus versicolor IgE Ab [Units/volume] in Serum

0.00

0.0

1.3

—

(3004446) Plasmodium sp identified in Blood by Light microscopy

0.91

0.00

2.8

2.7

—

(40759632) Porphyrins [Mass/mass] in Stool

0.00

0.0

1.1

—

(3015350) Toxocara sp Ab [Presence] in Serum

0.00

0.0

1.0

—

(3032868) Hemoglobin electrophoresis panel in Blood

1.00

0.00

1.3

1.5

—

(3002814) Trichinella spiralis Ab [Titer] in Serum

0.00

0.0

1.0

—

(3014591) Smooth Alder IgE Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma

1.00

0.00

1.1

6.0

9.2

u/l

—

Mortality – FinRegistry

↥

Association

Association between endpoint M13_GOUT and mortality.

Females

Parameter	HR [95% CI]	p-value
M13_GOUT	2.217 [2.0, 2.46]	< 0.001
Birth year	0.993 [0.99, 1.0]	0.088

During the follow-up period (1.1.1998 — 31.12.2019), 11540 out of 22477 females with M13_GOUT died.

Males

Parameter	HR [95% CI]	p-value
M13_GOUT	2.072 [1.86, 2.31]	< 0.001
Birth year	0.985 [0.98, 0.99]	0.001

During the follow-up period (1.1.1998 — 31.12.2019), 17217 out of 45017 males with M13_GOUT died.

Mortality risk

Mortality risk for people of age

years, who have M13_GOUT.

N-year risk	Females	Males
1	0.185%	0.328%
5	1.003%	2.263%
10	2.77%	5.535%
15	5.253%	10.185%
20	9.297%	16.467%

Relationships between endpoints

↥

Index endpoint: M13_GOUT – Gout

GWS hits: 19

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

rg [CI]

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Gout

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints